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Docosahexaenoic acid (DHA), an omega-3 fatty acid found in cold-water 
fish, has positive health benefits. While the suggested amount of 220 mg/day for 
adults may be attained by consuming fish, this may increase exposure to 
environmental pollutants. The heterotrophic marine alga Crypthecodinium cohnii 
is an important source of DHA because C. cohnii can accumulate lipid greater 
than 20% of their biomass with a large fraction of DHA (30-50%). Commercially, 
DHA production by C. cohnii is conducted in large bioreactors (~100 m3 capacity) 
using a batch-mode process. The purpose of this study was to investigate lipid 
and DHA production by C. cohnii using batch-mode and continuous-mode 
processes. The long term objective is to maximize DHA production from a safe 
and reliable marine source.   
Batch cultivation of C. cohnii was carried in a 15 L bioreactor vessel at 27 
˚C. C. cohnii (ATCC 30772) was grown in ATCC complex media 460 for 10 days 
at 25 °C, transferred to simple media (9 g/L glucose, 2 g/L yeast, and 25 g/L salt) 
and incubated statically for 8 days at 25 °C. Cultures were subsequently 
transferred to larger volumes of simple media and incubated at 25 °C in an orbital 
shaker incubator at 100 rpm.  At each transfer, a 10 % (v/v) inoculum level was 
maintained. Cultivation of C. cohnii was conducted in a 15 L computer controlled 
bioreactor vessel. Temperature was maintained at 27˚C by a computer controlled 
heating jacket. A 25% glucose solution was administered continuously at a rate 
of 0.78 mL/min.  
Continuous cultivation of C. cohnii was conducted in two 15 L computer 
controlled bioreactor vessels. Temperature of both vessels was maintained at 
27˚C during the growth mode of the study and standard media (25g/L glucose, 
5.5g/L yeast, and 25 g/L salt) was administered to both bioreactors. After 40 h, 
the system was switched to “continuous” mode where one vessel was 
maintained as a growth vessel at 27˚C, and the other as a lipid accumulation 
vessel at 17˚C. In continuous mode, standard media was administered to the 
growth vessel and a 25% glucose solution was administered to the lipid 
accumulation vessel. 
In both studies algal growth was monitored spectrophotometrically and 
measured every 12 h at 470 nm.  The biomass concentration, lipid content and 
fatty acid profile were determined by harvesting samples from the vessel.  
Results of the study showed that C. cohnii growth was achieved in batch-
mode and continuous-mode cultivation with lipid and DHA production. Maximum 
values for volumetric DHA productivity, biomass, lipid and DHA concentrations in 
the batch study were 3.61 mg/L.h, 8.35 g/L, 0.89 g/L and 0.32 g/L respectively. In 
continuous study the maximum values were 4.132 mg/L.h, 3.75 g/L, 0.55 g/L and 
0.145 g/L respectively. Although DHA concentration was higher in the batch 
mode process, volumetric DHA productivity of continuous mode process exceed 
volumetric DHA productivity of batch mode because of higher production rate of 
continuous mode process. These values did not exceed the reported values of 
other batch processes that used a 50 % glucose feed. More research is needed 
to optimize processing parameters in continuous mode to produce a viable 
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CHAPTER 1 - GENERAL INTRODUCTION 
The omega-3 fatty acids, eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), are polyunsaturated fatty acids (PUFA) that are 
commonly found in fish. α–Linolenic acid (ALA, 18:3) is the other common 
member of the omega-3 family of fatty acids and is the parent compound of EPA 
and DHA. In the human body, α–Linolenic acid (ALA, 18:3) is converted into both 
EPA and DHA, but the conversion rate is very slow (Al et al., 2000).  
DHA is an important PUFA in human breast milk and has positive health 
benefits. Health benefits of polyunsaturated fatty acids are well documented 
(Marszalek et al., 2005; Whelan et al., 2006; Ward et al., 2005; Simopoulos, 
1991, 1999, 2000 & 2001). Throughout gestation, the PUFA requirement of 
pregnant women is high and the fetus is dependent on maternal fatty acid intake 
(Al et al., 2000). Late gestation (last trimester) and early postnatal periods are 
critical times for neurological development; therefore, adequate maternal 
consumption of PUFAs, especially DHA, are important for the proper brain and 
retina developments of fetuses and infants during these periods (Marszalek et 
al., 2005).  
The most widely available source of EPA and DHA is cold water fatty fish 
types such as salmon, herring, mackerel, anchovies and sardines 
(Yongmanitchai et al., 1989). While the suggested amount of 220 mg/day DHA 
for adults may be attained by consuming fish, this may increase exposure to 
environmental pollutants. Furthermore, the use of fish oil in value added food 
products is limited because of its strong odor and distinct taste. Fish and fish oil 
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contain DHA and EPA together. The presence of EPA in fish oil is not desirable 
for infant food applications because EPA suppresses the endogenous ARA 
synthesis of infants resulting in their decreased growth rate (Carlson, 1996). 
Therefore, it is necessary to identify alternative sources that are safe, reliable 
and contain DHA as the primary PUFA.  
Microorganisms have long been known to be a source of “valuable” lipids 
because they are free of cholesterol, heavy metals, and pesticides; they are also 
high in PUFAs (Gunstone, 2001). Although fish is a very good source of DHA, 
they do not synthesize it but ingest it from sources in the marine food chain, 
primarily algae (Yongmanitchai & Ward, 1989). Commercial interest in the 
unicellular, heterotrophic, non-photosynthetic marine dinoflagellate 
Crypthecodinium cohnii is due to their capability to generate high amounts of lipid 
(>20 % of their biomass) with a DHA proportion between 30-50% and the 
absence of other PUFAs above 1% (Beach et al., 1973, 1974). Commercially, 
DHA production by C. cohnii is conducted in large bioreactors (~100 m3 capacity) 
using a batch-mode process. There are a limited number of studies about the 
growth of C. cohnii, lipid and DHA production, and capability of C. cohnii in batch 
mode cultivation (Beach et al., 1973, 1974; Ratledge et al., 1989, 2001, 2004; 
Kyle 1996; Swaaf et al., 1999, 2001, 2003a, 2003b). In these studies different 
carbon sources like glucose, ethanol and acetate; different growth temperatures; 
different substrate and salt concentrations have been investigated.    
Volumetric productivity of DHA (rDHA) is an important parameter to 
determine cost effectiveness of DHA production by algae. An increase in DHA 
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productivity will decrease product cost. The maximum rDHA reported to date for 
batch cultivation of C. cohnii in a standard medium containing glucose as the 
carbon source was 19 mg/L.h (Swaaf et al. 1999), with a 50 % glucose feed was 
14 mg/L.h (Swaaf et al. 2003a), with a pure acetic acid feed was 48 mg/L.h 
(Swaaf et al. 2003a), and with a pure ethanol feed was 53 mg/L.h (Swaaf et al. 
2003b).  The objective of the first study is to cultivate marine algae C. cohnii 
successfully with lipid and DHA production using a batch-mode cultivation 
strategy in larger bioreactor vessels using a 25 % glucose feed.    
At the time of this publication, there was no published work dealing with 
DHA and lipid production by C. cohnii in a continuous cultivation system; 
therefore, the purpose of the second study was to investigate growth, lipid and 
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CHAPTER 2 - REVIEW OF LITERATURE 
Polyunsaturated Fatty Acids  
Fatty acids having more than 18 carbon atoms with multiple double bonds 
are defined as long chain polyunsaturated fatty acids (PUFA). Depending on the 
location of the first double bond from the methyl end of the fatty acid, the 
unsaturated fatty acids are divided into three groups; omega-3 (n-3), omega-6 (n-
6) and omega-9 (n-9) with their first double bonds at the third, sixth and ninth 
carbon atoms from their methyl end, respectively.   
α–Linolenic acid (ALA, 18:3), the parent compound of eicosapentaenoic 
acid (EPA, 20:5) and docosahexaenoic acid (DHA, 22:6), are members of the 
omega-3 family of fatty acids. Omega-3 fatty acids are considered essential fatty 
acids because mammals are not able to add double bonds between carbons 
before the ninth carbon from the methyl end because they lack the desaturase 
enzymes responsible for this desaturation. Since DHA cannot be synthesized (de 
novo) by mammals, ALA must be ingested from dietary sources.  In the human 
body, ALA can be converted to both EPA and DHA, but the conversion rate is 
very low (Al et al., 2000, Yongmanitchai et. al., 1989).  
Importance of omega-3 PUFA  
Health benefits of polyunsaturated fatty acids are well documented 
(Marszalek et al., 2005, Whelan et al., 2006 and Ward et al., 2005). Omega-3 
EPA and DHA support heart health, cognitive health and development, mental 
health and eye health & development. Interest in PUFAs began when it was 
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reported that populations obtaining a substantial proportion of their fat intake 
from fish had a lower incidence of heart disease than other populations (Ward et 
al., 2005). The best source of omega-3 EPA and DHA is from oily fish like 
mackerel, anchovies and sardines (Yongmanitchai et al.1989; Ward et al., 2005) 
and is associated with a lower risk of fatal heart disease and stroke (Whelan et 
al., 2006). DHA is a major structural component of the gray matter of the brain, 
the eye retina, and heart tissue (Marszalek et al., 2005). The brain is 65 % lipid 
and DHA is a significant proportion of that (Whelan et al., 2006). Compared to 
other body tissues, the nervous system has been reported as having the highest 
concentration of PUFA, especially DHA (Marszalek et al., 2005).  
PUFAs contribute to fluidity, flexibility and selective permeability properties 
of membranes and so contribute important roles in membrane functioning (Ward 
et al., 2005). Furthermore, PUFAs contained in the phospholipid layer of the 
membranes are precursors for the synthesis of eicosanoids; like prostaglandins, 
leukotrienes and thromboxanes. Eicosanoids, hormone like substances, signal 
cellular responses to inflammation, vasodilation, blood pressure and fever. The 
eicosanoids from omega-6 arachidonic acid (ARA, 20:4) and EPA are different in 
terms of structure and function, and are even reported as antagonists (Ward et 
al., 2005). 
Health Effects of Omega-3 Fatty Acids  
The health effects of omega-3 fatty acids are anti-inflammatory, anti-
thrombotic, anti-arrhythmic, hypolipidemic and vasodilatory, whereas omega-6 
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fatty acids function as prothrombotic and proaggregatory (Simopoulos, 1999).  
Omega-3 fatty acids have a role in the secondary prevention of coronary heart 
disease, hypertension, type 2 diabetes, and, in some patients with renal disease, 
rheumatoid arthritis, ulcerative colitis, Crohn’s disease, and chronic obstructive 
pulmonary disease (Simopoulos, 1999). Omega-3 & omega-6 fatty acids are not 
inter-convertible in the human body (Simopoulos, 1991). Therefore, a balanced 
n-6/n-3 ratio in the diet would optimize growth and development, improve mental 
health, and decrease the risk for cardiovascular diseases and other chronic 
diseases (Simopoulos, 2000).  
PUFAs, particularly DHA and ARA, are highly concentrated in the cell 
membranes of the retina and brain. Late gestation (last trimester) and early 
postnatal periods are critical times for neurological development; therefore, 
adequate maternal consumption of PUFAs, especially DHA, are important for the 
proper brain and retina developments of infants during these periods (Marszalek 
et al., 2005). In the last trimester of gestation, ARA and DHA are transferred 
through the placenta, and supplied to the infant in breast milk during the first year 
of life (Marszalek et al., 2005). Greater levels of ARA and DHA are found in the 
phospholipids of erythrocytes of breast-fed babies relative to formula fed not 
supplemented with these PUFAs. It was concluded that infants had a limited 
capacity to convert linoleic acid (18:2) to ARA and ALA to DHA (Jensen & Heird, 
2002).  
The relationship between the sleep patterns of infants and maternal 
plasma PUFA concentrations were investigated (Cheruka et al., 2002). Plasma 
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phospholipid fatty acid concentrations of 17 women were measured at parturition 
while infants’ sleep and wake states were measured at postpartum day 1 and 
day 2. The infants of mothers with high-serum DHA had a significantly lower ratio 
of active sleep (AS) to quiet sleep (QS) and less AS than the infants of mothers 
with low-serum DHA. Infant sleep patterns are an expression of central 
integrative control; therefore, sleep and wake states of newborns were reported 
as providing a tool for assessing the functional integrity of their CNS. Infants born 
from mothers with higher plasma phospholipid DHA had a greater CNS maturity 
(Cheruku et al., 2002).  
Sources of DHA  
Fish, fish oil supplements, human milk, certain microbial oils and enriched 
products (oils, bakery products, fruit juice, infant formula, eggs, milk, mayonnaise 
and margarines) are dietary sources of DHA (Ward et al., 2005). Human milk is a 
good source of DHA, and since 2002 DHA has been added to infant formulas 
(Marszalek et al., 2005).   
 Fish are a major source of EPA and DHA with the PUFA content 
depending on the species and the geographic location of catching sites 
(Yongmanitchai et al., 1989). The most widely available source of EPA and DHA 
is cold water fatty fish types such as salmon, herring, mackerel, anchovies and 
sardines (Yongmanitchai et al., 1989). Fish and fish oil are thought to have some 
disadvantages. The first disadvantage linked with fish and fish oil is the co-
occurrence of EPA and DHA. EPA suppresses the endogenous ARA synthesis of 
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infants resulting in their decreased growth rate (Carlson, 1996). Furthermore, fish 
and fish oils may contain health threatening environmental contaminants such as 
heavy metals and fat-soluble pollutants like PCBs and dioxins (Ratledge, 2004). 
Some manufacturers remove heavy metals and other contaminants from fish oil 
through various means, such as molecular distillation. The use of fish oil in 
manufactured foods has sensory consequences due to the fishy odor.  The 
disadvantages with fish and fish oils accelerated the studies for alternative 
sources of PUFA and economical methods for PUFA production.   
Microbial Oils 
Animals and plants are the most common and traditional sources of lipids; 
however, animal sources may contain some environmental man-made pollutants 
and plants do not produce PUFA longer than 18 carbons (Ratladege, 2004). In 
order to get PUFA longer than 18 carbons from plant sources, genetic 
manipulation would be needed (Ratledge, 2004). Genetic manipulation includes 
the transfer of genes between different species. Genetic engineering is currently 
applied to oilseed plants for increased resistance to herbicides and pests, thus to 
increase yield (Gunstone, 2001). With genetic engineering the fatty acid 
composition of seed oil, chain length of fatty acids and level of unsaturation could 
be manipulated (Gunstone, 2001). However, genetically modified (GM) oils are 
not popular from the consumer perspective. 
Microorganisms have long been known to be a source of “valuable” lipids 
because they are free of cholesterol, heavy metals, and pesticides; they are also 
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high in PUFAs (Gunstone, 2001). The fatty acid profile of microbial oil depends 
on genetics of the species (Ratladege, 2004).  Microbial oils have been given 
GRAS (Generally Regarded As Safe) status by Food and Drug Administration.  
This has helped the single cell oils (SCO) industry in the market place, for 
example:  ARA and DHA from microbial oils are added to preterm and term infant 
formula. It is also recommended that pregnant and nursing women increase 
consumption of DHA-containing microbial oil (Ward et al., 2005) and DHA-rich 
oils are added to animal feed to increase the PUFA content of the meat 
(Simopoulos, 2000).  
A well known SCO producer company, Martek Biosciences Corporation 
(Columbia, MD, USA), has two patented products, DHASCO® and ARASCO®, 
which are permitted to be added to infant formula in the US. DHA in DHASCO® 
and ARA in ARASCO® were produced by Crypthecodinium cohnii and 
Mortieralla alpine respectively (Ratledge, 2004).  The benefits of these PUFAs 
and their use in some disease treatments will probably accelerate the production 
of microbial oils by variety of companies. 
Microbial oil biosynthesis 
Oleaginous microorganisms are defined as eukaryotic microorganisms 
capable of accumulating more than 20% of their biomass as lipid (Ratledge et al., 
1989). In some oleaginous microorganisms, the content of oil could even exceed 




 Figure 1. PUFA synthesis pathways of microorganisms using FAS route 
 
 In mammals the synthesis DHA starts with the precursor α- linolenic acid. 
In the DHA (also other PUFAs) synthesis pathway, some specific desaturase and 
elongase enzymes are employed for desaturation and elongation reactions. In 
the PUFA synthesis pathway of microorganisms using the fatty acid synthase 
(FAS) route, palmitic acid (16:0) is produced from acetyl CoA and malony CoA by 
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using FAS enzyme complex.  The saturated fatty acid is then converted to 
various PUFAs through a series of elongation and desaturation reactions. 
Besides this pathway, another PUFA biosynthesis mechanism called polyketide 
synthase (PKS) route has been reported for some marine prokaryotic and 
eukaryotic micro-organisms (Ratledge, 2004; Ward et al., 2005). Ratledge (2004) 
reported the synthesis of PUFA in Schizochytrium sp. and other related 
thraustochytrid marine protists via PKS.  For each microbial PUFA producer, 
identification of the oil accumulation pathways and key enzymes involved in 
these pathways is necessary to increase productivity and reduce product cost. 
Currently, there is no scientific work on the mechanism of DHA production as the 
primary PUFA in the biosynthesis pathway of C. cohnii. A better understanding of 
the lipid biosynthesis pathway of C. cohnii may result in increased productivity 
and decreased cost of this beneficial PUFA.  
 Microbial lipid accumulation is a biphasic process which requires an 
excess of carbon source over other nutrients especially nitrogen. Rapid cell 
growth occurs in the first phase while the second phase shows decreased growth 
and increased lipid synthesis and accumulation (Leman, 1997). Lipid 
accumulation is encouraged by growing the microorganism in a culture medium 
high in carbon and low in nitrogen (Ratledge, 2004). 
Commercial Production of DHA by Crypthecodinium cohnii 
 Fish are a good dietary source of DHA; however, they do not synthesize it.  
It is ingested from sources in the marine food chain, primarily by algae 
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(Yongmanitchai & Ward, 1989). Marine microorganisms such as heterotrophic 
dinoflagellates contribute significant amounts of DHA into the marine food chain 
because they can accumulate a high proportion of their lipid components as 
DHA. C. cohnii and strains from Traustochytrium (marine protists) are used 
commercially for DHA production. C. cohnii was the first microbial strain used for 
commercial production of DHA for infant formula (Ward et al., 2005). Commercial 
interest in the unicellular, heterotrophic, non-photosynthetic marine dinoflagellate 
C. cohnii has been stimulated by their capability to generate high amounts of lipid 
with a DHA proportion between 30-50% and the absence of other PUFA above 
1% (Beach et al., 1973, 1974).       
Commercially, DHA production by C. cohnii is conducted in large 
bioreactors or fermenters (~100 m3 capacity) using a batch-mode process. 
Commercial batch-mode production of DHA using C.cohnii was described by 
Kyle (1996). The sequence of processing steps was described as: 
“The pure cultures of one species are first grown in test tubes and they are 
systematically transferred to larger vessels where their temperature, pH, 
dissolved oxygen, pressure and agitation rate are monitored and controlled. 
When the culture reaches a determined cell density and fatty acid content, it is 
harvested by centrifugation and then spray-dried producing dry biomass. The 
purity of cultures are observed by inoculating culture broth samples onto agar 
plates at each transfer stage and also observed under microscope” Kyle (1996). 
  Kyle (1996) also described the method of DHASCO® (Martek Biosciences 
Corporation, Columbia, MD, USA) production which is the registered trade name 
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for the DHA rich oil, incorporated into infant formula. According to their process, 
the oil is extracted from the biomass by blending it with hexane, separated from 
the solids, separated from the solvent under vacuum and winterized to remove 
more highly saturated oil fractions. The winterized oil is refined, bleached, 
deodorized and finally diluted with high oleic sunflower oil to bring the DHA levels 
to an industry standard of 40 % (Kyle, 1996).  
 Specifications for different microbial strains for oil production include being 
non-pathogenic and non-toxin forming (Ward et al, 2005). C. cohnii has not 
demonstrated pathogenicity or toxigenicity (Kyle, 1996). Furthermore, 
commercial strains must be stable so that they do not lose the desirable oil 
producing characteristics over time to maintain consistency from batch to batch 
(Ward et al, 2005).  
Parameters affecting the growth of Crypthecodinium cohnii 
Environmental conditions such as temperature, media composition, 
aeration, agitation and culture age influence fatty acid biosynthesis and fatty acid 
composition of microalgae both qualitatively and quantitatively.  
The effect of temperature on growth and DHA production of C. 
cohnii 
Temperature is one of the most important environmental factors affecting 
the growth of C. cohnii and formation of DHA. The inhibition of cell growth of C. 
cohnii occurs at temperatures below 14°C or above 31°C with the optimum 
growth temperature of C. cohnii at 27°C (Beach et al., 1973).  
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Growth of C. cohnii in the temperature range of 20-35°C was investigated 
by Tuttle and others (1975). At 20-30°C, division cysts yield two cells; whereas, 
between 30-34°C an abnormal division where 30-40 % of the division cysts yield 
four cells, and a longer generation time of the cells were observed (Tuttle et al., 
1975).   
Jiang and Chen (2000) investigated the growth of C. cohnii over the 
temperature range of 15-30°C and reported the highest specific growth rate at 
30°C while the highest DHA content was obtained at 15°C at 72nd hour of 
cultivation. According to their study: 
“Culture of C. cohnii 30556 was maintained in liquid porphyridium with 5 
g/L glucose at 20 °C and sub-cultured every 7 days. This culture was used to 
inoculate the 100 mL flasks containing 20 mL porphyridium medium (with 5 g/L 
glucose) and incubated at 25 °C, 150 rpm for 48 h. The 100 mL flask were used 
to inoculate (5 % vol/vol) 250 mL flask containing 50 mL porphyridium medium 
and incubated at various temperatures (15 °C, 20 °C, 25 °C, 30 °C) & at 200 
rpm. The specific growth rates were determined by plotting the logarithm of 
culture optical density or dry weight concentration against time. The specific 
growth rate and biomass concentration of C. cohnii increased as the temperature 
increased while DHA proportion decreased” (Jiang and Chen, 2000). These 
results show that C. cohnii cultures grown at higher temperatures adapt 
themselves to the growth temperature by producing more saturated fatty acids; in 
contrast, they adapt themselves to the lower temperatures by increasing the 
degree of unsaturation and DHA proportions. The physiological adaptations of 
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microalgae to the growth temperature are considered to be regulated by enzyme 
reactions, cell permeability and cell composition which in turn affect the content 
of unsaturated fatty acids (Jiang and Chen, 2000).   
The growth of C. cohnii and lipid accumulation were compared at 
incubation temperatures of 27°C and 30°C by measuring optical density at 470 
nm (de Swaaf et al.,1998). At the 50th hour of the growth, the optical densities of 
the cultures grown at 27°C and 30°C were 4.7 and 5.8, respectively, indicating 
that growth was more stimulated at the higher incubation temperatures. At 27°C 
the DHA proportion of total lipid was 35.9% compared to 40.4% at 30°C; the 
greater proportion of DHA at increased incubation temperatures does not fit with 
the findings of Jiang and Chen (2000).  
Jiang and Chen (2000) investigated the effect of temperature shift on 
biomass concentrations and DHA production by using two temperature shift 
experiments in which algae grown at 30°C or 25°C for 48 h were transferred to a 
lower temperature (15 °C) environment and maintained there for another 24 h. 
They compared DHA contents and DHA productivity (volumetric productivity of 
DHA), of these two temperature shift cultures with cultures grown at the constant 
temperatures of 15°C, 20°C, 25°C or 30°C for 72 h. The DHA content (%DHA) 
and productivity (rDHA) of cultures grown at the static temperatures of 15°C, 
20°C and 25°C, as well as cultures grown with a temperature shift from 25°C to 
15°C, were all greater than those grown at 30°C or with temperature shift from 
30°C to 15°C. A temperature shift from 25°C to 15°C resulted in an increase in 
DHA content by 19.9% and DHA productivity by 6.5% as compared to that 
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maintained at 25°C for 72 h. DHA productivity (rDHA) of the culture grown with 
temperature shift from 30°C to 15°C was 0.79 mg/L.h while the culture grown at 
30°C for 72 h was 0.39 mg/L.h (Jiang and Chen, 2000). At 15°C (72 h), C. cohnii 
had a higher DHA proportion (57.64 % of total fatty acids) but a lower biomass 
concentration than the cultures grown at 20°C, 25°C and 30°C. DHA 
productivities were similar for all cultures grown at 15°C, 20°C and 25°C, but was 
highest (1.47 mg/L.h) with the temperature shift from 25°C to 15°C. In this study, 
temperature shift from 25°C to 15°C was indicated as an advantage in terms of 
DHA production (Jiang and Chen, 2000). 
The effect of carbon source on growth and DHA production of C. 
cohnii 
The effect of initial glucose concentration (25 g/L 50 g/L and 75 g/L) of 
media on batch growth of C. cohnii was tested (Swaaf et al., 1999).  All three 
media had the same yeast extract (5 g/L) and sea salt concentrations (17.8 g/L). 
Biomass concentrations were determined by optical density.  The highest optical 
densities were reached with 75 g/L glucose; however, initial growth rate 
decreased at concentrations above 25 g/L. The average doubling times between 
the 16th and 40th hour of growth were 10 h, 12.5 h and 13.8 h for 25 g/L, 50 g/L 
and 75 g/L glucose concentrations respectively (Swaaf et al., 1999). A 25 g/L 
glucose concentration showed highest growth rate for C. cohnii between 16-40 h 
as a result of lowest doubling time at this concentration.  The initial growth rate 
decreased at concentrations above 25 g/L.  
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Glucose and galactose were compared as carbon sources in batch 
cultivation of C. cohnii (Swaaf et al., 1999). C. cohnii cultures were grown in both 
glucose and galactose containing media resulting in similar DHA contents of 35.2 
% and 36.2 % of total lipid respectively. After 50 h of incubation, C. cohnii 
cultures grown in glucose media had reached optical density of 4.0 with 13.4% 
cell lipid content, while the cultures grown in galactose media reached optical 
density of 3.8 with 11.4 % cell lipid content (Swaaf et al., 1999).  
 C. cohnii can also be grown using acetic acid as the carbon source 
resulting in high cell densities with high DHA productivities (Ratledge et al.2001, 
Swaaf et al. 2003a). When microorganisms are grown in sodium acetate, a rise 
in pH is observed. The Na+ from sodium acetate remains in the growth medium 
and forms sodium hydroxide when combined with OH-. This rise in pH results in 
poor cell yield and is prevented in a pH auxostat culture system. In these 
systems, a low concentration of sodium acetate is included in the initial growth 
medium and acetic acid is used to maintain a constant pH value and to supply a 
further carbon source for growth. Ratledge et al., (2001) studied C. cohnii (ATTC 
30772) growth in a pH auxostat culture system with initial sodium acetate 
concentrations ranging from 1 g/L to 16 g/L. The strains were grown at 27 °C for 
4-5 days in ATCC medium 460 and then used to inoculate 100 mL of medium (9 
g/L glucose, 2 g/L yeast extract and 25 g/L sea salt) to be used as starter 
cultures. Shake flask cultures grown in 100 mL media containing 27 g/L glucose, 
3.8 g/L yeast extract and 25 g/L sea salt were inoculated with static cultures at 10 
% inoculation value.  The shake flask cultures were used to inoculate 1 L 
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fermenter containing 800 mL media composed of 7.5 g/L yeast extract, 25 g/L 
sea salt and different concentrations of sodium acetate changing between 1-16 
g/L.  Small (1 L) pH-auxostat cultures grown at 27 C for 3 days were used to 
inoculate (5 % vol/vol) larger (5 L) fermenter containing 3.5 L the same media of 
1 L fermenter.  The pH and dissolved oxygen concentration was maintained at 
6.5 and 30 % respectively. For growth with glucose as principal carbon source, 
shake flask cultures were used to inoculate1 L fermenter and then 5 L fermenter 
containing the same media of shake flasks. After 140 h of growth, the growth rate 
and cell density were greatest at 8 g/L sodium acetate concentration.  This 
concentration resulted in the highest lipid content in the cell; however, the sodium 
acetate concentration in the medium had no significant effect on the proportion of 
DHA (Ratledge et al., 2001). The accumulation of lipid by C. cohnii in pH 
auxostat batch culture with acetic acid as the principal carbon source was also 
compared with batch cultures grown in glucose as principal carbon source.  Both 
lipid and DHA production were greater in the acetic acid culture than the glucose 
culture (Ratledge et al., 2001). Ratledge et al., (2001) were also compared six 
strains of C. cohnii cultures at 8 g/L sodium acetate concentration. The strains 
investigated were ATCC 30772, ATCC 30541, ATCC 50298, ATCC 40750, 
ATCC 30555 & ATCC 3055. C. cohnii ATCC 30772 was the best of six cultures 
tested because it had the greatest DHA yield between the 98th and 144th hour of 
cultivation. This strain reached 20-30 g/L dry biomass and contained more than 
40% total lipid with DHA accounting half of the total fatty acids.  
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Fed-batch cultures refer to a batch culture fed continuously or with an 
intermittent manner with media. Glucose and acetate were compared as carbon 
sources in the fed batch cultivation of C. cohnii (Swaaf et al., 2003a). In glucose 
grown cultures, the feed rate was manually adjusted to maintain a residual 
glucose concentration between 5 and 20 g/L throughout the fermentation; in 
acetic acid grown cultures the feed rate was controlled via culture pH. Between 
90 h and 120 h cultivation with 50% glucose, the final volumetric production rate 
was 14 mg/L.h while cultivation with 50% acetic acid resulted in a maximum 
value of 38 mg/L.h at 210th hour. When the cultures were fed with pure acetic 
acid instead of 50% solution in water, a further increase in volumetric productivity 
was observed: between 150 h and 400th h cultivation, the final volumetric 
production rate was 48 mg/L.h. With pure acetic acid feed, the final biomass, lipid 
and DHA concentrations reached were 109 g/L, 61 g/L and 19 g/L respectively, 
and these were the highest values reported to the date for heterotrophic alga 
(Swaaf et al., 2003a).   
The potential of ethanol as a carbon source was also investigated by 
Swaaf et al. (2003b).  In shake flask cultures, growth did not occur at 
concentrations above 15 g/L but occurred at the concentrations of 5 and 10 g/L. 
The specific growth rate was optimal at 5 g/L ethanol (Swaaf et al. 2003b). In an 
ethanol grown fed batch cultivation of C. cohnii, 300 g pure ethanol was added 
over a total fermentation time of 220 h. The volumetric production rate (rDHA) 
reached a maximum of 53 mg/L and the final concentrations of biomass dry 
weight, lipid and DHA were 83 g/L, 35 g/L and 11.7 g/L respectively. The results 
 
23 
of these studies showed that the volumetric production rate for DHA (rDHA) in 
ethanol grown (fed-batch) cultures was higher than the highest rDHA values of 
the cultures grown in glucose (19 mg/L.h) and in acetic acid (48 mg/L.h) (Swaaf 
et al. 2003b).  Although DHA content of the lipid produced by C. cohnii was the 
same in both acetic acid and ethanol grown cultures and the total lipid content 
was higher in the acetic acid than ethanol grown cultures, the ethanol grown 
cultures resulted in a considerably higher DHA because of the faster biomass 
production (Swaaf et al. 2003b).  
The effect of salinity on growth and DHA production of C. cohnii   
Growth of C. cohnii is favored by supplementing NaCl to the culture 
medium. Marine microalgae require NaCl to maintain the osmotic balance of the 
cells. Cells respond to salinity changes by adjusting their specific growth rates 
and cellular fatty acid composition. The reduced polyunsaturated fatty acids at 
increased salinities results in a reduction in membrane fluidity and permeability. 
The reduced membrane fluidity and permeability was reported as an 
improvement of the performance of the algae at high salinity to prevent leakage 
of compatible solutes out of the cell and diffusion of potential growth inhibitory 
ions into the cell (Jiang and Chen, 1999).  
The effect of salt on the growth of C. cohnii was tested with NaCl 
concentrations ranging from 0.3 to 5 %.  Growth was inhibited at 0.3 and 5 % and 
failed in the absence of NaCl (Beach et al., 1973).  
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Swaaf et al. (1999) studied the effect of sea salt on growth and lipid 
accumulation of C. cohnii with NaCl concentrations ranging from 2.8 to 27.8g/L in 
media containing 9 g/L glucose and 2 g/L yeast extract. Both growth and lipid 
accumulation were stimulated by increasing salinity.  For optimal growth and lipid 
accumulation the minimal required sea salt concentration was 17.8 g/L, which is 
about half of the average sea water salinity. Similar growth and lipid 
accumulation was observed at both 27.8 and 17.8 g/L sea salt concentrations 
(Swaaf et al., 1999). 
 Jiang and Chen (1999) investigated the effects of salt concentrations on 
cell growth and DHA content of C. cohnii ATCC 30556, C. cohnii ATCC 50051 
and C. cohnii RJH. NaCl concentrations were in the range of 0-35 g/L.  No 
growth was observed when the medium did not contain NaCl and at NaCl 
concentrations above 30 g/L. The specific growth rate of C. cohnii ATCC 30556 
was greatest at 9 g/L NaCl, while the other two strains were greatest at 5 g/L. 
The highest biomass concentration was achieved at 9 g/L NaCl yielding 2.51 g/L 
for C. cohnii ATCC 30556 and 1.56 g/L for C. cohnii ATCC 50051.  The highest 
biomass concentration was achieved at 5 g/L NaCl yielding 2.49 g/L for C. cohnii 
RJH. At 9 g/L NaCl, C. cohnii ATCC 30556 had the highest DHA proportion (56.9 
% of total fatty acids) while C. cohnii ATCC 50051 and C. cohnii RJH reached 
their highest DHA contents (54.6 % and 55.7 % respectively) at 5 g/L NaCl. At 
NaCl concentrations above the optimum value of C. cohnii, a decrease in specific 
growth rate due to the salinity adaptation was also reported. The reported 
modification of cellular fatty acid composition and changes in specific growth 
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rates in response to the salinity changes for all three cells indicated that salinity 
was an important factor influencing the growth and chemical composition of the 
C. cohnii (Jiang and Chen, 1999).  
The effect of yeast extract on growth, lipid and DHA production 
of C. cohnii 
Yeast extract concentration of media is another important parameter 
affecting growth and DHA productivity of C. cohnii. The effect of yeast extract 
with concentrations ranging from 0 g/L to 10 g/L was studied in a medium 
composed of 9 g/L glucose and 27.8 g/L sea salt (Swaaf et al., 1999). At a yeast 
extract concentration of 1 g/L, optical density (OD) and lipid content of the 
biomass was 3.8 and 20 %, respectively.  At a yeast extract concentration of 5 
g/L these values were 5.8 and 6 %, respectively. 
 When Swaaf et al. (2001) studied the effect of yeast extract on viscosity 
the yeast extract concentration was increased from 7.5 g/L to 15 g/L. By doubling 
the yeast extract concentration, the biomass increased from 17.1 g/L to 21.4 g/L, 
while the lipid content of the cells decreased from 13.8 % to 5.1% (Swaaf et al., 
2001).  These results indicated that increasing amounts of yeast extract 
stimulated growth however lipid accumulation was negatively affected (Swaaf et 
al., 1999, 2001).  
  Ratledge et al. (2001) tested the effects of independently varying 
concentrations of yeast extract and sea salt in growth medium of C. cohnii in a 
pH-auxostat culture with acetic acid and found no significant improvement in lipid 
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accumulation or DHA production by modest increases or decreases in yeast and 
sea salt concentrations. 
The effect of oxygen availability, agitation, culture viscosity and 
pH on growth and DHA production of C. cohnii 
Oxygen tension is another important parameter affecting the growth of C. 
cohnii.  Cells with an enhanced supply of O2, from flask or fermentor cultures, 
multiply more rapidly than cells grown with a restricted supply of oxygen (Beach 
& Holz, 1973). 
Tutle & Loeblich (1975) investigated the importance of aeration and 
reported that rotary agitation in flask at 40 and 80 rev/min exponentially killed C. 
cohnii cells.  Microscopic examination showed disintegration of the cells caused 
by this agitation. They also reported that aeration by bubbling sterile air at the 
rate of 1.8 l/min and agitation by stirring the culture with Teflon coated magnet at 
the rate of 200 rev/min did not increase the growth significantly. It was decided 
that oxygen supply was not a limiting factor in their culture conditions. In contrast 
to Tutle & Loeblich’s (1975) findings, Swaaf et al. (1999) reported a significant 
improvement in the growth of C. cohnii by increasing the agitation speed from 50 
to 100 rpm in shaken flask cultivations. According to their study, optical density 
(OD) reached at 100 rpm was more than four times higher than the OD found for 
the culture grown at 50 rpm at the 50th hour of cultivation.  This increase was 
thought due to the enhanced oxygen supply. In addition, microscopic 
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examination of the cells revealed absence of any detrimental effects by agitation 
at 50-100 rpm (Swaaf et al.,1999).  
Viscosity is especially important in high scale industrial cultivations, 
affecting both volumetric productivity of DHA (rDHA) and cost of the high cell 
density cultivation process. An increase in viscosity increases the need for heavy 
stirring which then increases the energy cost component of productions. In 
addition, an increase in agitation will produce more heat, which in turn will cause 
an increased need for cooling, resulting in higher energy costs. Swaaf et al. 
(2001) investigated the effects of culture viscosity on oxygen availability and the 
possible causes of this viscosity. Extra-cellular polysaccharides were produced 
by C. cohnii (batch growth) in a media composed of glucose, yeast extract and 
sea salt. The presence of these extra-cellular polysaccharides increased 
viscosity and decreased the oxygen transfer by decreasing oxygen transfer 
coefficient (Swaaf et al., 2001). Increased viscosity complicates the high cell 
density cultivation and thus DHA production. The effect of yeast extract on 
culture viscosity was tested and found that by doubling yeast extract 
concentration from 7.5 g/L to 15 g/L, the biomass increased from 17.1 g/L to 21.4 
g/L. The viscosity of the supernatant also increased from 4.0 mm/s2 to 5.6 mm/s2 
(Swaaf et al., 2001). Culture viscosity affects the oxygen transfer from the gas 
phase to the culture broth in a negative manner, as the culture viscosity 
increases it becomes difficult to supply cultures with sufficient dissolved oxygen. 
Efficient gas transfer is more difficult to achieve in large scale bioreactors than 
small scale bioreactors because large scale bioreactors have a lower maximal 
 
28 
oxygen transfer coefficient (k1A) than small scale laboratory bioreactors (Swaaf 
et al., 2001).  
Swaaf et al (2003 a) tested the effect of a polysaccharide hydrolyzing 
enzyme preparation Glucanex® (Novo Nordisk, Neumatt, Switzerland) on C. 
cohnii culture supernatant viscosity. The addition of 1 g/L Glucanex led to an 
immediate increase in dissolved oxygen concentration and automatic reduction 
of the stirrer speed without a change in metabolic activity. The addition of 0.5 g/L 
Glucanex was also found to reduce viscosity compared to media without 
Glucanex (Swaaf et al., 2003 a).  
Tuttle and Loeblich (1975) examined the growth of C. cohnii at the range 
of pH (5.2-7.0). The pH for optimum growth was found as 6.6. Most published 
studies (Ratledge et al. 2001, Swaaf et al. 1999, 2001, 2003a, 2003b and 2003c) 
maintained pH at 6.5 which is very close to the optimum pH found by Tuttle and 
Loeblich in 1975. Furthermore, limited growth was reported below pH 5.2 (Tuttle 
and Loeblich, 1975). 
The objective of this study is the successful cultivation of the marine alga 
C. cohnii with lipid and DHA production using a continuous cultivation strategy 
rather than batch. The long term objectives are to maximize DHA production from 
microbial sources. This research is expected to develop methodologies that will 
improve current process techniques to maximize DHA production from a safe 
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CHAPTER 3 – FED-BATCH CULTIVATION OF C. COHNII  
 
ABSTRACT 
Crypthecodinium cohnii (ATCC 30772) was revived and grown in ATCC 
complex media 460 for 10 days at 25 °C, transferred to simple media (9 g/L 
glucose, 2 g/L yeast, and 25 g/L salt) and incubated statically for 8 days at 25 °C. 
Cultures were subsequently transferred to larger volumes of simple media and 
incubated at 25 °C in an orbital shaker incubator at 100 rpm.  At each transfer, a 
10 % (v/v) inoculum level was maintained. Batch cultivation of C. cohnii was 
conducted in a 15 L computer controlled bioreactor vessel. Temperature of 
bioreactor was maintained at 27˚C by a computer controlled heating jacket. A 
25% glucose solution was administered continuously at a rate of 0.78 mL/min. 
Algal growth was monitored spectrophotometrically and measured every 12 h at 
470 nm.  The biomass concentration, lipid content and fatty acid profile were 
determined by harvesting samples from the vessel every 24 h. Results of the 
study showed that C. cohnii growth was achieved in batch-mode cultivation with 
lipid and DHA production. Maximum volumetric DHA productivity (3.61 mg/L.h) 
was achieved at the 71st hour of the cultivation. Maximum biomass, fat and DHA 
concentrations achieved were 8.35 g/L, 0.89 g/L and 0.32 g/L, respectively.  
These values did not exceed the reported values of other batch processes that 
used a 50 % glucose feed. With fed-batch and continuous cultures dilution rate is 
an important parameter affecting the growth because the substrate concentration 
in the culture broth is dependent on the dilution rate. The use of 25 % glucose 
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solution versus 50 % or inappropriate feed rate may cause the growth inhibition 
by the substrate. In order to exceed the previous reported values the feed 
(media) rate, the composition of the feed and the concentration of the glucose 
solution should be optimized.  
INTRODUCTION 
Docosahexaenoic acid (DHA) is a long chain poly unsaturated fatty acid 
with 22 carbons and 6 double bonds. DHA belongs to the omega-3 group of fatty 
acids and is an important structural fatty acid found in neural tissue and in heart 
tissue. The phospholipids of the brain and retina are characterized by high 
contents of omega-3 fatty acids, particularly by DHA (Cheruku at al. 2002). Thus, 
DHA is important for the normal brain and retina development of fetuses and 
infants (Marszalek et al. 2005). Maternal DHA status is significantly influenced by 
dietary DHA and it is associated with maturity of the central nervous systems of 
infants at birth (Al et al. 2000, Cheruku at al. 2002). 
The most widely available source of DHA is cold water fatty fish. Although 
fish is a very good source of DHA, they do not synthesize it but ingest it from 
sources in the marine food chain, primarily by algae (Yongmanitchai & Ward, 
1989). Two groups of marine organisms, Crypthecodinium cohnii and 
thraustochytrid group, are used for the commercial production of DHA rich oil 
(Ward et al., 2005). Marine algae C.cohnii is capable of synthesizing lipid with a 
high proportion of DHA (30-50%) with the absence of other PUFAs above 1% 
(Beach et al., 1973&1974). Commercial production of DHA is conducted by a 
 
35 
very limited number of companies, in large bioreactors using a batch-mode 
cultivation process.  
The purpose of this study was to achieve successful cultivation of C. 
cohnii with a batch mode process and to investigate biomass, lipid and DHA 
accumulation during the cultivation period. The experience gained by this study 
will help lead to the successful continuous cultivation of C.cohnii.  The long term 
objective of this research is to maximize DHA production from a safe and reliable 
marine source.  
 
MATERIALS AND METHODS 
 Algal Cultures 
 A Crypthecodinium cohnii (ATCC 30772) ampoule was stored at -80ºC in 
an Ultra low temperature freezer (U535, New Brunswick Scientific, Edison, NJ).  
The ampoule was thawed at room temperature and aseptically transferred to 5 
mL ATCC growth medium 460 in a screw-capped test tube. ATCC growth 
medium 460 was composed of: 23.48 g/L NaCl; 10.63 g/L MgCl2 6H2O; 3.92 g/L 
Na2SO4; 1.11 g/L CaCl2; 0.66 g/L KCl; 0.19 g/L NaHCO3; 0.1 g/L KBr; 0.03 g/L 
H3BO3; 0.04 g/L SrCl2 6H2O; 3.0 ml Metal Mixture (0.03 g/L EDTA; 0.05 g/L FeCl3 
6H2O; 1.0 g/L H3BO3; 0.15 g/L MnCl2 4H2O; 0.1 g/L ZnCl2; 0.005g/L CoCl2 6H2O; 
100.0 ml distilled deionized water (ddH2O)); 0.01 g/L FeCl3 6H2O; 0.15 g/L 
sodium glycerophosphate; 0.05 g/L (NH4)2SO4; 3.0 g/L TRIS buffer, 1.0 mL 
Vitamin Solution (0.003 g/L biotin; 1 g/L thiamine hydrochloride; 1.0 L ddH2O); 
0.01 g/L K2HPO4; 3.0 g/L glucose; 1.5 g/L glutamic acid; and 1.0 L ddH2O).  Test 
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tube caps were screwed on tightly and then loosened one half turn.  Cultures 
were statically incubated upright at 25ºC for 10-14 days (as the manufacturer 
suggested) in a Fisher Scientific Isotemp Economy Incubator (537D, Hampton, 
NH).  The cultures were sub-cultured by screwing the cap on tightly, inverting the 
culture 5 times, and aseptically transferring a 0.1 mL to 5 mL ATCC growth 
medium 460 in screw-capped test tubes. The sub-culturing process was 
repeated every 10-14 days. 
 
Strain, media and maintenance of cells 
Static sub-cultures (0.1 mL) were aseptically transferred to test tubes 
containing 5 mL media (9 g/L glucose, 2 g/L yeast extract and 25 g/L sea salt) 
and incubated statically at 25 ˚C for 8 days. Cultures were aseptically transferred 
to a 250 mL flask containing 50 mL media (9 g/L glucose, 2 g/L yeast extract and 
25 g/L sea salt) at an inoculation level of 10% v/v and incubated at 25 ˚C for 3 
days in a shaker incubator (C24, New Brunswick Scientific, Edison, NJ) at 100 
rpm. The contents of the flask were then transferred to 500 mL flasks each 
containing 100 mL media (25 g/L glucose, 5.5 g/L yeast extract and 25 g/L sea 
salt) and incubated in a shaker incubator (100 rpm) at 25 ˚C for 3 days.  These 
cultures were used for inoculation of the bioreactors at an initial inoculation level 
of 10% v/v.   
Bioreactors 
Fed-batch cultivation was performed in a computer controlled (Biostat® 
Twin Controller, Sartorius BBI Systems, Bethlehem, PA, USA) 15 L bioreactor 
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vessel.  Temperature of the vessel was maintained at 27˚C using a computer 
controlled heating jacket (Sartorius BBI Systems, Bethlehem, PA, USA).  The 
initial medium in the bioreactor was composed of 5 g/L glucose, 10 g/L yeast 
extract, 25 g/L sea salt and 0.5 g/L commercial polysaccharide hydrolyzing 
enzyme (Lysing Enzymes from Trichoderma, Sigma Aldrich Inc, St. Louis, MO). 
The pH was maintained at 6.5 by automatic addition of 2.5 M NaOH and 3 M 
HCl. A 25% glucose solution was administered continuously at a rate of 0.78 
mL/min. Foam production was suppressed by addition of antifoam B (Astoria-
Pacific, Clackmas, OR, USA) 1 drop/L as needed. Dissolved oxygen was 
maintained at 30 % by computer controlled flushing with filter sterilized air and by 
stirring.  
Calculation of the Flow Rates   
In the study done by Swaaf et al. (1999), average glucose feed rate was 
1.06 g glucose/h for the first 75 hours.  This value of feed rate was used as the 
basis for flow rate calculations. Accordingly, the feed rate for a 50 % glucose 
solution in water was calculated as: 
(1.06 g glucose/h) x (100 mL soln/50 g glucose) x (h/60 min) = 0.035 mL/min (for 
1 L start up volume) 
Since thin fluids have lower viscosity than thick fluids, 25 % solution was 
preferred in place of 50 % to decrease the resistance of fluid to flow. With 25 % 
glucose feed the flow rate was doubled (multiplied by 2) to supply culture the 
same amount of glucose as with 50 %. 
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Accordingly, the feed rate for a 25 % glucose solution and 11 L start up 
volume was calculated as: 
(0.035 mL/min) x 2 x (11 L) = 0.78 mL/min 
Growth of Cells 
Optical density and biomass concentration were used to evaluate growth 
over time.  Samples (3-5 mL) were aseptically removed from the bioreactor 
vessel twice a day over the course of the cultivation period.  Optical density was 
measured spectrophotometrically at 470 nm (Swaaf, 1999).  Approximately 1 L of 
culture was harvested each day from the bioreactor vessel so that biomass 
concentration could be ascertained.  The sample was centrifuged (10,000g at 
5˚C for 10 min) and the pellet was rinsed once with 50 ml dH2O, lyophilized, and 
weighed.  Biomass concentration was calculated by dividing the weight of freeze 
dried sample to the volume of sample solution centrifuged for that freeze dried 
sample quantity. 
Analysis of Fatty Acids 
 
Fat and fatty acids were extracted from biomass by the acidic hydrolysis 
method (AOAC Official Method 996.06). Pyrogallic acid was added to minimize 
oxidative degradation of fatty acids during analysis. Triglyceride, triundecanoin 
(C11:0), was used as internal standard. Fat was extracted into ether, then 
methylated to fatty acid methyl esters (FAMEs) using boron trifluoride (BF3) in 
methanol (Appendix A). FAMEs were quantitatively measured by capillary gas 
chromatography against the C11:0 internal standard. All samples were analyzed 
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on a gas-liquid chromatography (Agilent Technologies, Model 7890A) equipped 
with a 7683B series Injector. Helium was used as the carrier gas with a 0.75 
mL/min flow rate. The temperature program for separations began at 100oC, held 
for 4 min, increased to 240oC at 3oC/min and held for 15oC. Temperatures for 
injector and detector were 225 and 285oC respectively. Peaks were identified by 
comparing their retention times with references. 
Total fat was calculated as sum of individual fatty acids expressed as 
triglyceride equivalents. 
Statistical Analysis 
The batch cultivation experiment was conducted once with observations in 




RESULTS AND DISCUSSION 
Growth of C. cohni, with lipid and DHA production, was achieved in batch- 
mode cultivation. Optical density was used to evaluate growth over time, C. 
cohnii reached homeostasis by 50th h of cultivation (Figure 2). Optical density 
(470 nm) at the 17 th h of cultivation was 1.3 and reached maximum value of 
2.41. 
 Maximum biomass concentration was achieved by 45 h cultivation, 
followed by a gradual reduction until the 89th hour of cultivation (Figure 3). 
Maximum biomass concentration was 8.35 g/L (at 45th hour of bioreactor 
cultivation). Swaaf et al. (2003a) reported a final maximum biomass 
concentration of 26 g/L over a cultivation period of 120 h with 50 % glucose 
solution feed. 
Fat content of biomass increased steadily between 24th and 137th hours of 
the bioreactor cultivation. An increase from 3.60 % to 14.0 % was observed 
during this period of time (Figure 3 and Table 1).  This shows a positive 
relationship between the fat content and cultivation time. Swaaf et al. (2003a) 
reported a maximum lipid content of 15 % (at 90th hour of cultivation) with 50 % 
glucose feed which is very close to our maximum value reached (14%) with 25 % 
glucose feed. 
The proportion of DHA in the lipid also increased steadily between 24 th 
and 137 th hours of the bioreactor cultivation. An increase from 15.4 % to 36.60 % 
was observed during this period of time (Figure 3 and Table 1).  Like the lipid 
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content, a positive relationship was observed between the DHA content and age 
of the culture. Maximum DHA percentage achieved was 36.7 % at 116 th hour of 
cultivation. Swaaf et al. (2003a) reported a maximum value of 46 % for DHA 
percentage with 50 % glucose feed. 
 Maximum lipid and DHA concentrations were 0.89 g/L and 0.32 g/L 
respectively (Figure 4). However, these values were quite low compared to the 
previously reported maximum values of 3.8 g/L and 1.7 g/L with 50 % glucose 
fed batch process (Swaaf et al., 2003a).  
The rDHA is the value of volumetric DHA productivity per liter of the 
harvest per hour. Maximum volumetric DHA productivity achieved at the 71 th 
hour of bioreactor cultivation was 3.61 mg/L.h (Figure 4). Swaaf et al. (2003 a) 
reported  maximum rDHA with 50 % glucose feed culture as14 mg/L.h. 
Compared to 14 mg/L.h, the rDHA of this study (3.61 mg/L.h) was quite low. The 
use of 25 % glucose solution in place of 50 % might account for some portion of 
this difference. Since of 25 % glucose solution contains more water, it will dilute 
the culture more and so will decrease the cell density.  A 25 % solution was 
preferred in place of 50 % to decrease the resistance of fluid to flow and to 
provide better flow. Although cultivation of C. cohnii with lipid and DHA 
production was achieved, high cell densities could not be achieved. There are a 
number of reasons for this result. As stated previously, 25 % glucose solution 
used in this study diluted the culture more than 50 % glucose solution used in the 
previous study (Swaaf et al. 2003a). By flow rate adjustment the same amount of 
glucose as with 50 % glucose solution pumped to the bioreactor vessel with 25 % 
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glucose solution but more water. Also, shifts in temperature and dissolved 
oxygen concentrations may have had an effect on cell concentration. Initially, the 
temperature of bioreactor vessel was set to 27 ˚C; however, a rise in temperature 
(+2.8 ˚C) was observed.  Therefore, the set temperature was reduced to 25 ˚C.  
The temperature reduction was not enough to maintain the vessel at 27 ˚C.  This 
may be due to a heat producing chemical reaction by the alga (biological heat) 
and/or heat of friction by agitation in the vessel.  Swaaf et al. (2003a) pointed out 
cooling problems in large scale reactors due to biological heat production and 
power input via mixing. In an attempt to cool the contents of the growth vessel, 
the heating jacket was removed and the vessel was cooled by air movement. 
Temperature was maintained at 26.5 +/- 0.5 ˚C from the 17th h through the 
duration of the growth phase of cultivation (41st h).  There were no remarkable 
changes in optical density during 48-65 hrs of cultivation possibly due to an 
interruption in oxygen flow. From the start to the end of the cultivation, lipid 
content of biomass & DHA content of lipid increased steadily; however, the 
previously reported maximum biomass concentration (26 g/L) was not achieved 
(Swaaf et al. 2003a). Biomass concentration and the volumetric productivity are 
the most important parameters reflecting the DHA production capacity of 
processes. Future research will look at the ways to increase biomass 
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Figure 3. Biomass concentration (BC), Lipid content of dry biomass (lipid %) and DHA 


















































Figure 4. Lipid concentration, volumetric productivity of DHA (rDHA) and DHA 

























































Table 1. Fat (%) and fatty acid profile of C. cohnii over time in a batch mode process 
Cultivation time 24 41 48 65 89 113 137
Lipid % (g Lipid/100g 
dry Biomass) 3.74 4.785 7.005 11.355 12.135 13.245 13.975
DHA  (g DHA/100g 

















Docosahexaenoic acid (DHA), an omega-3 fatty acid, has positive health 
benefits. The heterotrophic marine alga Crypthecodinium cohnii is an important 
source of DHA because C. cohnii can accumulate lipid greater than 20% of their 
biomass with a large fraction of DHA (30-50%). Commercially, DHA production 
by C. cohnii is conducted in large bioreactors (~100 m3 capacity) using a batch-
mode process. The purpose of this study was to investigate lipid and DHA 
production by C. cohnii using a novel, continuous-mode process.   
Continuous cultivation of Crypthecodinium cohnii was conducted in two 15 
L computer controlled bioreactor vessels. Temperature of both vessels was 
maintained at 27˚C during the growth mode of the study and standard media 
(25g/L glucose, 5.5g/L yeast, and 25 g/L salt) were administered to both 
bioreactors. After 40 h, the system was switched to “continuous” mode where one 
vessel was maintained as a growth vessel at 27˚C, and the other as a lipid 
accumulation vessel at 17˚C. In continuous mode, standard media were 
administered to the growth vessel and a glucose (25 %) solution was administered 
to the lipid accumulation vessel. Results showed that C. cohnii growth was 
maintained in continuous production. Maximum values for DHA productivity, 
biomass, lipid and DHA concentrations were 4.132 mg/L.h, 3.75 g/L, 0.55 g/L and 
0.145 g/L respectively. More research is needed to optimize processing 
parameters in continuous mode to produce a viable alternative to batch mode 
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processes.  Future research will look at the effect of different temperatures, 
carbon sources and feed rates on C. cohnii growth, lipid and DHA accumulation in 
continuous mode process. 
INTRODUCTION 
Long chain polyunsaturated fatty acids, especially docosahexaenoic acid 
(DHA) has positive health benefits. The phospholipids of the brain and retina are 
characterized by high contents of omega-3 fatty acids, particularly by DHA 
(Cheruku at al. 2002). Thus, DHA is an essential nutrient particularly during 
periods of rapid tissue growth and is important for the proper brain and retina 
development of fetuses & infants (Marszalek et al., 2005). The most widely 
available source of DHA is cold water fatty fish. However, fish oil supresses the 
endogenous arachidonic acid (ARA) synthesis of infants resulting in decreased 
growth rate (Carlson, 1996). For this reason, it is banned in the USA for use in 
infant formula (Ratledge, 2004; Carlson, 1996). Furthermore, the use of fish oil in 
the food industry is limited because of its strong smell and taste. The application 
of DHA for human and animal nutrition is a fast growing market. Therefore, it is 
necessary to supply this demand and to identify safe, cost effective alternatives. 
 Microorganisms have long been known to be a source of “valuable” lipids 
because they are free of cholesterol, heavy metals, and pesticides; they are also 
high in polyunsaturated fatty acids (PUFAs) (Gunstone, 2001). Crypthecodinium 
cohnii is a very good candidate for a DHA source because it is capable of 
producing a high proportion (30-50%) of lipid as DHA (Beach et al., 1973). 
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Commercially, DHA production by C. cohnii is conducted in large bioreactors 
using a batch-mode process. There are a limited number of studies that report 
lipid and DHA production by C. cohnii in batch mode cultivation; no published 
work has been found on lipid and DHA production by C. cohnii in continuous 
cultivation. The purpose of this study was to investigate lipid and DHA production 
by C. cohnii using a novel, continuous-mode process.  The long term objective of 
this research is to improve the existing cultivation methods of the marine alga C. 
cohni and to maximize production of DHA.  
MATERIALS AND METHODS 
Strain, media and maintenance of cells 
 An ampoule of C. cohnii (ATCC 30772) was stored at -80ºC in an UltraLow 
temperature freezer (New Brunswick Scientific, Edison, NJ, U535). The ampoule 
was thawed at room temperature and aseptically transferred to 5 mL ATCC 
growth medium 460 in a screw-capped test tube. ATCC growth medium 460 was 
composed of: 23.48 g/L NaCl; 10.63 g/L MgCl2 6H2O; 3.92 g/L Na2SO4; 1.11 g/L 
CaCl2; 0.66 g/L KCl; 0.19 g/L NaHCO3; 0.1 g/L KBr; 0.03 g/L H3BO3; 0.04 g/L 
SrCl2 6H2O; 3.0 mL metal mixture (0.03 g/L EDTA; 0.05 g/L FeCl3 6H2O; 1.0 g/L 
H3BO3; 0.15 g/L MnCl2 4H2O; 0.1 g/L ZnCl2; 0.005g/L CoCl2 6H2O; 100.0 ml 
distilled deionized water (ddH2O)); 0.01 g/L FeCl3 6H2O; 0.15 g/L sodium 
glycerophosphate; 0.05 g/L (NH4)2SO4; 3.0 g/L TRIS buffer, 1.0 mL vitamin 
Solution (0.003 g/L biotin; 1 g/L thiamine hydrochloride; 1.0 L ddH2O); 0.01 g/L 
K2HPO4; 3.0 g/L glucose; 1.5 g/L glutamic acid; and 1.0 L ddH2O). Test tube 
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caps were screwed on tightly and then loosened one half turn.  Cultures were 
incubated statically upright at 25ºC for 10-14 days (537 D, Fisher Scientific 
Isotemp Economy Incubator, Hampton, NH).  The culture was sub-cultured by 
screwing the cap on tightly, inverting the culture 5 times, and aseptically 
transferring a 0.1 mL to 5 mL ATCC growth medium 460 in screw-capped test 
tube. The sub-culturing process was repeated every 10-14 days so that a fresh 
culture was available throughout the study. 
Strain, media and maintenance of cells 
Static sub-cultures (0.1 ml) were aseptically transferred to test tubes 
containing 5 mL media (9 g/L glucose, 2 g/L yeast extract and 25 g/L sea salt) 
and incubated statically at 25 ˚C for 8 days. Cultures were aseptically transferred 
to a 250 mL flask containing 50 mL media (9 g/L glucose, 2 g/L yeast extract and 
25 g/L sea salt) at 10 % inoculation level (v/v) and incubated at 25 ˚C for 3 days 
in a shaker incubator at 100 rpm. The contents of the flask were then transferred 
to 500 mL flasks each containing 100 mL media (25 g/L glucose, 5.5 g/L yeast 
extract and 25 g/L sea salt) at 10 % inoculation level (v/v) and incubated in a 
shaker incubator at 25 ˚C for 3 days.  These cultures were used for inoculation of 
the bioreactors at an initial inoculum’s level of 10% v/v.   
Bioreactors 
Large scale cultivation of C. cohnii was conducted in two 15 L computer 
controlled bioreactor vessels.  The temperature of both vessels was maintained 
at 27˚C during the batch mode of the study (the first 40 h) using a computer 
controlled heating jacket.  The initial medium was composed of 25 g/l glucose, 
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5.5 g/l yeast extract, 25 g/l sea salt and 0.5 g/L commercial polysaccharide 
hydrolyzing enzyme (Lysing Enzymes from Trichoderma, Sigma Aldrich Inc, St. 
Louis MO). The pH was maintained at 6.5 by automatic addition of 3 M NaOH 
and 3 M HCl. During the batch phase of continuous production (the first 40 h), 
fresh media (25 g/l glucose, 5.5 g/l yeast extract, 25 g/l sea salt) was 
administered continuously to both bioreactors. After 40 hours, the system was 
switched to continuous mode where one of the bioreactor was maintained as a 
growth vessel at 27 ˚C and the other became a cooling vessel at 17 ˚C. Figure 5 
represents the flow chart of the system. Foam production was suppressed by the 
addition of antifoam B (Astoria-Pacific, Clackmas, OR, USA) 1 drop/L as needed. 
Dissolved oxygen was maintained at 30 % by computer controlled flushing with 
filter sterilized air and by stirring (150-350 rpm).  
Calculation of the Flow Rates  
Swaaf et al. (1999) administered 19 g glucose to their cultures within the 
first 40 hours of cultivation; therefore, this value of feed rate was used as the 
basis of feed rate calculations for the batch mode cultivation in our current study: 
(19 g glucose/40 h) x (1 L media/25 g glucose) x (1000 mL/L x h/60 min) = 0.32 
mL/min (per each 1 L start up volume) 
According to Swaaf’s study (1999), after 40-43 h the growth rate 
decreased slowly and had ceased completely after 74 h.  Therefore, the flow rate 
of culture from the growth vessel to the lipid accumulation vessel for the duration 
of the continuous mode study was as follows: 
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For 5.5 L initial volume, the feed rate of media was: 5.5 x 0.32 mL/min = 1.76 
mL/min 
The total volume in both bioreactors after 40 h was calculated as: 
5.5 L + (1.76 mL/min x 60 min/1 h x 40 h x 1 L/1000 mL) = ~ 9.72 L 
Flow rate of culture from the growth vessel to the lipid accumulation vessel was 
calculated as:  
(9.72 L/(74-40 h) x (h/60 min) x (1000 mL/L) = ~4.75 mL/min  
The flow rate of 4.75 mL/min was also used for the feed rate of fresh 
media to the growth vessel. Since glucose solution (25 %) contains 10 times of 
glucose in media, 0.475 mL/min was used as the glucose feed rate to the lipid 
accumulation vessel (Appendix C). 
Growth of Cells 
Optical density and biomass concentration were used to evaluate growth 
over time. Spectrophotometric measurements (Life Science UV/vis 
spectrophotometer Model DU 530, Beckman Coulter, Fullerton, CA) were read at 
470 nm and were taken from both vessels every 12 h for the duration of the 
study. Biomass concentration was determined by harvesting a ~ 1 L sample 
every 24 h from the cooling vessel. The sample was centrifuged 10,000 x g at 
5˚C for 10 min, supernatant poured off, and rinsed once with dH2O.  The pellet 
was then lyophilized and weighed before storage at – 80 ˚C. Biomass 
concentration was calculated by dividing the weight of the freeze dried sample 
with the volume of sample solution centrifuged. 
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Analysis of Fatty Acids 
Fat and fatty acids were extracted from biomass by acidic hydrolysis 
method AOAC Official Method 996.06. Pyrogallic acid was added to minimize 
oxidative degradation of fatty acids during analysis. Triglyceride, triundecanoin 
(C11:0), was used as internal standard. Fat was extracted into ether, then 
methylated to fatty acid methyl esters (FAMEs) using boron trifluoride (BF3) in 
methanol (Appendix A). FAMEs were quantitatively measured by capillary gas 
chromatography against C11:0 internal standards. All samples were analyzed on 
a gas-liquid chromatography (Agilent Technologies, Model 7890A) equipped with 
a 7683B series Injector.  Helium was used as the carrier gas with a 0.75 mL/min 
flow rate. The temperature program for separations began at 100oC, held for 4 
min, increased to 240oC at 3oC/min and held for 15oC. Temperatures for injector 
and detector were 225 and 285oC. Peaks were identified by comparing their 
retention times with references. Total fat was calculated as sum of individual fatty 
acids expressed as triglyceride equivalents. 
Statistical Analysis 
The study was conducted three times with at least two observations from 
each.  Data were analyzed using multiple linear regressions (MS Office 2003), 
analysis of covariance (ANCOVA) and Tukey’s Honestly Significant Differences 




RESULTS AND DISCUSSION 
Growth of C. cohnii with lipid and DHA production was achieved in this 
continuous study. Figure 6 represents growth, measured spectrophotometrically 
at 470 nm, of C. cohnii over time in a continuous mode process. Growth was 
significantly different during the third replication of the study (P < 0.05) in terms of 
OD in the growth vessel and OD in cooling vessel (P<0.05). The average OD 
reached in the growth vessel at the 40th h and the cooling vessel at the 113th 
hour was 2.05+/-0.05 and 2.2+/-0.05 respectively.  These results are similar to 
the results of preliminary study, where all parameters were the same with this 
current study except that cells were cultivated and harvested in a batch mode.  
Figure 7 represents the biomass concentration of harvest from the cooling 
vessel over in the continuous mode process. Biomass concentrations ranged 
from 2.0 g/L to 4.2 g/L over the cultivation period.  Biomass concentration was 
significantly different during the third replication of the study (P < 0.05), possibly 
due to temperature fluctuations in the growth vessel during the other replications 
of the study.  Temperature is one of the most important environmental factors 
affecting the growth of C. cohnii and formation of DHA. Growth of C. cohnii 
declines at temperatures below 14°C or above 31°C, the optimum growth 
temperature of C. cohnii was reported to be 27°C (Beach et al., 1973).  During 
the first and second repetition of the study, the temperature of the growth vessels 
exceeded the optimum growth temperatures reported by others.  During the 
second repetition, a spike in biomass concentration occurred at the 160th h, 
which corresponds to the maximum temperature of 34.2°C.  
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Maximum biomass concentration occurred during the third repetition and 
maintained an average of 3.70 g/L from the 88th h through the 160th h of 
cultivation.  In batch mode processes, the reported maximum biomass 
concentrations exceeded those achieved in this continuous study.  Ratledge et 
al. (2001) reported a value of 17 g/L (at 140 h) for biomass concentration in pH 
auxostat cultures, Swaaf et al. (2003a) reported 26 g/L in glucose solution (50 %) 
fed batch culture, 51 g/L in acetic acid solution (50 %) fed batch culture and 61 
g/L in pure acetic acid fed batch culture (Swaaf et al., 2003a). High cell density 
was not achieved in our continuous system.  
Figure 8 represents lipid percentages of cooling vessel during different 
cultivation time in the continuous mode process. Lipid proportion of dry biomass 
was significantly different during the second replication of the study (P < 0.05) 
from the other replications of the study. Lipid proportion followed an increasing 
trend until 112th h and maintained an average of 14.5 g/L from the 112th h 
through the 160th h of cultivation during the third repetition. Maximum lipid 
proportion of dry biomass occurred during the first repetition (17.37 %) at 117 th 
hour of cultivation. Ratledge et al. (2001) reported a value of 44 % for lipid in pH 
auxostat culture system. The other reported lipid % values by Swaaf et al. 
(2003a) were 15 % lipid for fed batch culture with 50 % glucose, 54 % lipid for fed 
batch culture with 50 % acetic acid and 49 % lipid for fed batch culture with 100 
% acetic acid. According to these results it can be concluded that acetic acid as 
principal carbon source would yield more lipid than glucose.  
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Figure 9 represents DHA yield (% of lipid) of the cooling vessel at different 
cultivation times in the continuous mode process. DHA proportion of lipid was 
significantly different during the second replication of the study (P < 0.05) from 
the other replications of the study. DHA proportions of lipids followed an 
increasing trend until 112th h and maintained an average of 27% of lipid from the 
112th h through the 160th h of cultivation during the first and third replication of the 
study. Maximum DHA percentage occurred during the first repetition (29.90%) at 
95th hour of cultivation.  Ratledge et al. (2001) reported 59 % of lipid as DHA % 
(% of total fatty acids) at 140 th h of cultivation in pH-auxostat cultures with acetic 
acid as principal carbon source. This value is double our maximum value.  Swaaf 
et al. (2003a) reported a maximum value of 46 % DHA in a fed batch cultivation 
with 50 % glucose solution at 120 h while they reported 29 % for 50 % acetic acid 
fed and 32 % with 100 % acetic acid fed batch cultivation at 210 h (Swaaf et al., 
2003a).  
Figure 10 represents lipid concentrations of the cooling vessel over time in 
the continuous mode process. Lipid concentration was significantly different 
during the third replication of the study (P < 0.05) from the other replications of 
the study. A state of homeostasis for lipid concentration was observed in Rep 3 
between 110 h and 160 h. Maximum lipid concentration occurred during the third 
repetition (0.55 g/L) at 137th hour of cultivation. This value was less than the 
previous reported maximum values of 3.7 g/L in batch cultivation (Swaaf et al., 
1999), 7.5 g/L in pH auxostat culture with acetic acid as principal carbon source 
(Ratledge et al., 2001) and 30 g/L with 100 % acetic acid fed batch cultivation 
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(Swaaf et al., 2003a). Preliminary yields in a batch study with glucose solution 
(25 %) feed were 0.89 g/L, exceeding the yields attained with the continuous 
cultivation strategy.  
 Figure 11 represents DHA mass flow rate (DHA productivity) of cooling 
vessel at different cultivation time in continuous mode process. According to the 
statistical analysis, DHA productivity (DHA mass flow rate) of Rep 2 was 
significantly less than Rep 1 and Rep 3. Maximum DHA mass productivity 
(mDHA) was achieved in Rep 3 (41.32 mg /h). The maximum DHA volumetric 
productivity found in the preliminary batch study with glucose solution (25 %) fed 
culture was 3.61 mg/L.h. The rDHA is the value of DHA productivity per liter of 
the harvest per hour while mDHA is the value of DHA productivity per hour. 
Therefore, the maximum mDHA from the preliminary batch mode would be 36.1 
mg/h for 10 L harvest while it was found 41.32 mg/h (for 10 L) in the continuous 
mode process. Even though the maximum biomass of the continuous-mode 
process (3.75 g/L) was less than the preliminary batch-mode (8.35 g/L), the DHA 
mass productivity (mDHA) of continuous-mode (41.32 mg/h) was greater than 
batch-mode process (36.1 mg/h). This is due to a greater product output in the 
continuous study. Swaaf et al. (2003 a) reported maximum rDHA in glucose 
solution (50 %) fed culture, acetic acid solution (50 %) fed culture and pure acetic 
acid fed culture, 14 mg/L.h, 38 mg/L.h and 45 mg/L.h, respectively. 
Figure 12 represents DHA concentrations of the cooling vessel over time in 
the continuous mode process. DHA concentration was significantly different 
during the second replication of the study (P < 0.05) from the other replications of 
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the study. Maximum DHA concentration occurred during the third repetition 
(0.145 g/L) at 127th hour of cultivation. This value was less than the previously 
reported maximum values of 1.6 g/L in batch cultivation (Swaaf et al., 1999), 4.4 
g/L in pH-auxostat culture with acetic acid as principal carbon source (Ratledge 
et al., 2001) and 9.5 g/L with 100 % acetic acid fed batch cultivation (Swaaf et al., 
2003a). Maximum DHA concentration was greater in the glucose solution (25 %) 
fed batch preliminary batch mode study (0.32 g/L).   
In conclusion, optimal media and glucose solution concentrations, feed 
rates, flow rates and process conditions need to be determined so that high cell 
densities can be achieved in a continuous mode process. Temperature is a very 
important factor affecting the growth of C. cohnii and formation of DHA. Growth 
of C. cohnii declines at temperatures below 14°C or above 31°C. Higher 
incubation temperatures enhance growth but reduce DHA accumulation. So, 
optimum temperatures for both the growth vessel and for the cooling vessel need 
to be determined. In addition to feed rates, flow rates and process conditions, 
carbon source is also very important factor affecting the growth of C. cohnii and 
DHA productivity. For optimum growth and lipid accumulation, carbon sources 
(glucose vs. acetate) need to be compared in the continuous mode process.  If 
the high cell densities of the previous batch mode studies can be achieved with 
the continuous mode process, the volumetric productivity could be improved 
significantly. Improvement in the current DHA production techniques could lead 
to a cost effective and reliable source of DHA for use in value added foods and 
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the health benefits of DHA could be realized without the risk of exposure to the 
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Figure 6. Growth of C. cohnii over time in a continuous mode process.  
Samples were taken from a growth vessel maintained at 27oC and a lipid accumulation 
vessel where temperature was dropped to 17oC after 40 h cultivation at 27oC. Growth 
was measured spectrophotometrically at 470 nm.  Straight line represents samples taken 
from the growth vessel and dotted line represents samples from the cooling vessel.  
Symbols represent Δ – Repetition 1, Ο – Repetition 2, ■ – Repetition 3 
 







































































































































































































Figure 11. DHA mass flow rate (DHA productivity) of cooling vessel over time in 


























































Table 2. Fat (%) and Fatty acid profile of C. cohnii over time in the continuous mode 
process 
 
Cultivation time (h) 40 64 88 112 136 160 
Rep1 
Lipid % (g Lipid/100g 
dry Biomass) 
       
6.29  
     
11.63  
     
15.06  
     
18.56  
     
16.21   -  
DHA  (g DHA/100g 
Lipid) 
     
25.93  
     
26.83  
     
29.79  
     
29.02  
     
27.63   -  
Rep2 
Lipid % (g Lipid/100g 
dry Biomass)  -  
       
4.76  
       
7.71  
       
8.07  
       
9.36  
       
6.17  
DHA  (g DHA/100g 
Lipid)  -  
     
10.35  
     
16.64  
     
16.53  
     
15.88  
     
10.26  
Rep3 
Lipid % (g Lipid/100g 
dry Biomass) 
       
4.65  
       
8.64  
     
13.13  
     
14.57  
     
15.27  
     
13.80  
DHA  (g DHA/100g 
Lipid) 
     
22.71  
     
22.15  
     
26.99  
     
27.72  
     
26.64  




























APPENDIX A. Fatty Acid Analysis 
 
Extraction of Fats 
Homogenized freeze-dried biomass was placed in a Mojonnier flask with 
pyrogallic acid (100 mg), 2mL triglceride internal standard (C:11, triundecanoin) 
solution (5 mg/mL in CHCl3) and boiling granules.  Ethanol (2mL) was added and 
mixed until entire test portion was in solution. Ten mL HCl (8.3 M) was added 
and mixed. The flask was then placed in a shaking water bath at 70-80 °C set at 
moderate agitation speed and maintained for 40 min. The contents of flask were 
mixed using a vortex mixer every 10 min to incorporate particulates adhering to 
the sides of flask. The flask was removed from the water bath and allowed to 
cool to room temperature (20-25 °C). Ethanol was added until it filled the bottom 
of the flask reservoir and mixed gently. Diethyl ether (25 mL) was then added to 
the flask. The flask was closed off with a stopper, placed in centrifuge basket in 
wrist action shaker and agitated for 5 min. The stopper was rinsed into flask with 
diethyl ether-petroleum ether mixture. Petroleum ether (25 mL) was added, the 
flask closed off and agitated for another 5 min. The contents of the flask were 
separated by centrifugation (5 min at 600 x g) and rest until the upper layer was 
clear. Again, the stopper was rinsed into flask with diethyl ether-petroleum ether 
mixture. The top layer (ether) was transferred into 150 mL beaker and ether was 
evaporated slowly on steam bath, using nitrogen stream to aid in evaporation. 




After complete drying with nitrogen gas, 2-3 mL chloroform and 2-3 mL 
diethyl ether were added to dissolve the extracted fat residue. This mixture was 
transferred to a glass vial and evaporated to dryness in 40 °C water bath under 
nitrogen stream. Two mL, 7 % BF3 reagent and 1 mL toluene were added to the 
vial. The vial was sealed with a screw cap top containing a Teflon/silicone 
septum and heated in oven 45 min at 100 °C. The vial was agitated gently every 
10 min and allowed to cool to room temperature (20-25 °C). After addition of 5 
mL H2O, 1 mL hexane and 1 g Na2SO4, the vial was capped and agitated 1 min. 
The contents of vial were allowed to rest so that layer separation could occur.  
The top layer containing the FAMEs was then transferred to another vial 















APPENDIX B.  Fatty Acid Profile 
BATCH MODE       1        2  
      
1        2        1        2        1        2        1        2        1        2        1        2  
Cultivation time 
(h) 17 17 24 24 48 48 65 65 89 89 113 113 137 137 
Fat (by acid 
hydrolysis) 3.79 3.69 4.75 4.82 6.99 7.02 11.33 11.38 12.11 12.16 13.26 13.23 14 13.95 
Myristic (14:0) 6.6 6.68 8.97 8.9 10.9 10.74 14.98 14.82 13.67 13.58 13.31 13.1 13.21 13.18 
  Myristoleic 
(14:1) 8.65 8.45 4.9 4.93 3 2.94 1.53 1.51 0.88 0.86 0.88 0.86 0.75 0.76 
(C15:0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Palmitic (16:0) 11.95 11.94 19.2 18.94 24.51 24.22 27.22 26.87 27.3 27.11 28.39 27.86 27.66 27.65 
  Palmitoleic 
(16:1) 11.27 10.93 6.6 6.49 3.52 3.47 1.88 1.84 1.53 1.52 1.49 1.45 1.48 1.49 
(17:0) 3.04 2.94 1.5 1.49 0.82 0.8 0.34 0.34 0.25 0.25 0.24 0.23 0.21 0.21 
   (17:1) 0 0 0 0 0.94 0.98 1.15 1.13 0.89 0.93 0.84 0.84 0.74 0.79 
Stearic (18:0) 1.72 1.61 1.81 1.76 1.93 1.9 1.78 1.76 1.7 1.68 1.75 1.71 1.68 1.69 
  Elaidic (18:1t9) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
  Oleic (18:1n9)  3.77 3.62 5.43 5.19 5.98 5.87 6.09 6.04 8.26 8.19 8.65 8.46 8.77 8.79 
  Vaccenic 
(18:1n7) 0 0 2.68 2.6 2.84 2.85 1.87 1.82 0 0 0 0 0 0 
  Linoleic (18:2) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
  Linolenic 
(T18:3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
  (T18:4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Arachidic (20:0) 0 0 0 0 0 0 0.2 0.2 0.22 0.21 0.22 0.22 0.22 0.23 
  (20:1n9) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
  (20:3 T3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
  Arachidonic 
(20:4n6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
  Arachidonic 
(20:4 T3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
  (20:5 T3; 
EPA) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Docosanoic 
(22:0) 0 0 0 0 0 0 0.19 0.19 0.21 0.2 0.24 0.24 0.23 0.25 
  Erucic (22:1n9) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
  (22:5 T3; 
DPA) 0 0 0 0 0 0 0 0 0.25 0.24 0.27 0.26 0.28 0.27 
  (22:6 T3; 
DHA) 15.4 16 24.7 25.2 29.72 30.17 28.21 28.43 35.08 35.6 34.71 35.82 36.74 36.56 
Lignoceric 
(24:0) 0 0 0 0 0 0 0 0 0.17 0.17 0.2 0.18 0.18 0.21 
  Nervonic 











Rep1 1 2 1 2 1 2 1 2 1 2 
Cultivation time 
(h)  40 40  64  64  88  88  112  112  136  136  
Fat (by acid 
hydrolysis) 6.55% 6.02% 11.60% 11.66% 14.89% 15.22% 18.42% 18.70% 16.22% 16.19% 
Fatty Acid Profile (Expressed as Percent of Total Fat) 
  
Myristic (14:0) 10.55 10.28 15.15 14.91 18.52 18.56 17.82 17.72 17.77 17.85 
  Myristoleic 
(14:1) 3.87 3.83 1.07 1.05 0.83 0.83 0.95 0.94 0.93 0.93 
(C15:0) 0.39 0.38 0.14 0.14 0 0 0 0 0 0 
Palmitic (16:0) 13.53 13.2 20.75 20.65 19.46 19.48 20.17 20.13 20.41 20.42 
  Palmitoleic 
(16:1) 5.16 5.08 4.01 3.99 2.85 2.85 3.22 3.21 3.05 3.05 
(17:0) 2.03 2 0.57 0.57 0.3 0.29 0 0 0 0 
   (17:1) 0.62 0.62 1.4 1.45 0.43 0.41 0.83 0.8 0.79 0.78 
Stearic (18:0) 1.71 1.49 1.21 1.28 1.26 1.08 1.2 1.29 1.16 1.14 
  Elaidic (18:1t9) 0.31 0.25 0 0.11 0.08 0 0.07 0.09 0.07 0.07 
  Oleic (18:1n9)  7.41 7.23 8.3 8.16 11.96 11.96 12.43 12.37 12.2 12.22 
  Vaccenic 
(18:1n7) 0 0 4.15 4.19 0 0 0 0 0 0 
  Linoleic (18:2) 0 0 0 0 0 0.08 0 0 0 0 
  Linolenic 
(T18:3) 0 0 0.25 0.26 0 0.09 0.18 0.18 0.18 0.17 
  (T18:4) 0 0 0 0 0 0 0 0 0 0 
Arachidic (20:0) 0 0 0.19 0.12 0.17 0.16 0.15 0.15 0.15 0.15 
  (20:1n9) 0 0 0.12 0.12 0 0 0.07 0.08 0.08 0.07 
  (20:3 T3) 0 0 0 0 0 0 0.06 0.08 0.13 0.1 
  Arachidonic 
(20:4n6) 0 0 0 0 0 0 0 0 0 0 
  Arachidonic 
(20:4 T3) 0 0 0 0 0 0 0 0 0 0 
  (20:5 T3; EPA) 0 0.18 0 0 0 0.09 0 0 0 0 
Docosanoic (22:0) 0 0 0.11 0.11 0.13 0.13 0.13 0.15 0.15 0.14 
  Erucic (22:1n9) 0.19 0.19 0.11 0.15 0.13 0.1 0.11 0.12 0.16 0.18 
  (22:5 T3; DPA) 0.37 0.25 0.21 0.2 0.27 0.27 0.31 0.33 0.26 0.25 
  (22:6 T3; DHA) 26.03 25.82 27.14 26.52 29.7 29.87 29.09 28.94 27.56 27.69 
Lignoceric (24:0) 0.33 0.19 0.11 0.14 0.12 0.13 0.13 0.14 0.09 0.1 
  Nervonic 











Rep2 1 2 1 2 1 2 1 2 1 2 
Cultivation time (h) 64  64  88  88  112  112  136  136  160 160 
Fat (by acid 
hydrolysis) 4.39% 5.12% 7.95% 7.47% 8.36% 7.78% 9.26% 9.45% 6.28% 6.05% 
Fatty Acid Profile 
(Expressed as 
Percent of Total Fat)                     
Myristic (14:0) 8.1 8.39 11.55 11.63 11.15 11.33 11.38 11.28 8.1 7.72 
  Myristoleic (14:1) 5.64 5.78 5.02 5 6.02 5.9 6.63 6.72 10.58 11 
(C15:0) 0.34 0.32 0.23 0.23 0.26 0.26 0.23 0.23 0 0 
Palmitic (16:0) 20.04 20.52 19.3 19.41 14.99 15.02 14.22 14.3 13.53 13.24 
  Palmitoleic (16:1) 6.22 6.34 6.13 6.11 7.33 7.25 6.65 6.71 8.94 9.22 
(17:0) 1.34 1.36 0.8 0.83 0 0 0 0 0 0 
   (17:1) 4.14 4.39 3.34 3.08 3.43 3.35 3.07 3.3 3.64 3.68 
Stearic (18:0) 1.55 1.45 1.38 1.46 0.87 1.11 0.96 0.97 1.26 0.98 
  Elaidic (18:1t9) 0.21 0.2 0.17 0.21 0.17 0.21 0.22 0.22 0.28 0.25 
  Oleic (18:1n9)  2.56 2.69 6.59 6.67 7.35 7.63 7.69 7.68 4.5 4.25 
  Vaccenic (18:1n7) 5.45 5.62 4.93 4.92 4.17 4.05 3.05 3.01 4.21 4.32 
  Linoleic (18:2) 0 0.22 0 0 0 0 0 0 0 0.22 
  Linolenic (T18:3) 0.99 0.91 0.65 0.67 0.73 0.7 0.65 0.64 0.68 0.74 
  (T18:4) 0 0 0 0 0 0 0 0 0 0 
Arachidic (20:0) 0 0 0 0 0 0 0 0 0 0 
  (20:1n9) 0 0 0 0 0.15 0.14 0.17 0.16 0 0.19 
  (20:3 T3) 0 0 0.23 0.24 0.35 0.31 0.34 0.34 0.47 0.46 
  Arachidonic (20:4n6) 0 0 0 0 0 0 0 0 0 0 
  Arachidonic (20:4 
T3) 0 0 0 0 0 0 0 0 0 0 
  (20:5 T3; EPA) 0 0 0 0 0 0 0 0 0 0 
Docosanoic (22:0) 0 0 0 0 0 0 0 0 0 0 
  Erucic (22:1n9) 0 0.2 0.17 0 0.17 0.16 0.14 0.13 0 0 
  (22:5 T3; DPA) 0 0 0.25 0.28 0.22 0.2 0.2 0.18 0 0.19 
  (22:6 T3; DHA) 10.18 10.52 16.82 16.46 16.36 16.7 15.96 15.79 10.55 9.96 
Lignoceric (24:0) 0 0.23 0 0 0 0 0 0 0 0 














Rep3 -1 1 2 3 1 2 3 1 2 3 
Cultivation time (h) 40 40 40 64 64 64 88 88 88 
Fat (by acid hydrolysis) 4.65% ** 4.65% 8.92% 8.35% 8.64% 13.28% 12.97% 13.13% 
Fatty Acid Profile (Expressed as 
Percent of Total Fat)                   
Myristic (14:0) 8.27 8.07 8.6 14.75 14.46 14.31 15.39 15.41 15.4 
  Myristoleic (14:1) 8.55 8.6 0 1.45 1.46 0 1.09 1.09 0 
(C15:0) 0.32 0.31 0 0 0 0 0 0 0 
Palmitic (16:0) 11.34 11.16 11.24 14.52 14.3 14.16 15.96 16 15.62 
  Palmitoleic (16:1) 6.97 6.99 6.88 7.31 7.26 7.34 5.29 5.31 5.26 
(17:0) 1.72 1.71 0 0.66 0.69 0.66 0 0 0 
   (17:1) 0.7 0.67 0.97 1.05 1.27 0 2.06 2.05 0 
Stearic (18:0) 2.05 1.98 1.98 0.93 0.97 1.06 0.74 0.75 0.75 
  Elaidic (18:1t9) 0.19 0.16 0.31 0 0 0 0.11 0 0 
  Oleic (18:1n9)  6.96 6.68 6.75 11.39 11.02 16.45 13.78 13.92 13.44 
  Vaccenic (18:1n7) 0 0 0 5.52 5.67 0 0 0 0 
  Linoleic (18:2) 0 0 0 0 0 0 0.1 0 0 
  Linolenic (T18:3) 0 0 0 0.21 0.18 0.22 0.3 0.3 0 
  (T18:4) 0 0 0 0 0 0 0 0 0 
Arachidic (20:0) 0 0 0 0 0 0 0.11 0.11 0.16 
  (20:1n9) 0 0 0 0 0 0.23 0.09 0.09 0 
  (20:3 T3) 0 0 0 0 0 0 0.14 0.16 0 
  Arachidonic (20:4n6) 0 0 0 0 0 0 0 0 0 
  Arachidonic (20:4 T3) 0 0 0 0 0 0 0 0 0 
  (20:5 T3; EPA) 0 0 0 0 0 0 0 0 0 
Docosanoic (22:0) 0 0 0 0 0 0 0.08 0.09 0 
  Erucic (22:1n9) 0.3 0.34 0 0.14 0.17 0 0.11 0.11 0 
  (22:5 T3; DPA) 0.36 0.39 0.58 0.28 0.28 0.82 0.28 0.29 1.19 
  (22:6 T3; DHA) 23.1 22.55 22.48 22.75 22.51 21.2 27.36 27.44 26.16 
Lignoceric (24:0) 0 0.17 0 0 0 0.21 0 0 0.18 
















Rep3-2 1 2 3 1 2 3 1 2 3 
Cultivation time (h) 112 112 112 136 136 136 160 160 160 
Fat (by acid hydrolysis) 14.72% 14.42% 14.57% 15.21% 15.32% 15.27% 13.98% 13.61% 13.80% 
Fatty Acid Profile 
(Expressed as Percent of 
Total Fat)                   
Myristic (14:0) 15.18 15.2 15.25 15.55 15.59 15.8 14.85 14.99 14.51 
  Myristoleic (14:1) 1.05 1.07 0 5.44 5.37 0 7.08 6.95 0 
(C15:0) 0 0 0 0 0 0 0 0 0 
Palmitic (16:0) 15.59 15.56 15.54 15.23 15.23 15.07 14.43 14.53 13.64 
  Palmitoleic (16:1) 5.53 5.52 5.59 6.02 5.97 5.96 6.77 6.7 6.54 
(17:0) 0 0 0 0 0 0 0 0 0 
   (17:1) 2.02 2.03 0 1.85 1.74 0 1.71 1.64 0 
Stearic (18:0) 0.71 0.72 0.78 0.74 0.75 0.75 0.79 0.81 0.86 
  Elaidic (18:1t9) 0.11 0.11 0 0.1 0.11 0 0.12 0.12 0 
  Oleic (18:1n9)  12.49 12.5 12.39 12.35 12.36 12.16 8.75 8.75 11.3 
  Vaccenic (18:1n7) 0 0 0 0 0 0 3.46 3.49 0 
  Linoleic (18:2) 0 0 0 0 0 0 0 0 0 
  Linolenic (T18:3) 0.29 0.29 0 0.27 0.29 0 0.28 0.29 0 
  (T18:4) 0 0 0 0 0 0 0 0 0 
Arachidic (20:0) 0.11 0.11 0.16 0.11 0.11 0.16 0.11 0.11 0.26 
  (20:1n9) 0.09 0.09 0 0.09 0.09 0 0.09 0.09 0 
  (20:3 T3) 0.15 0.15 0 0.14 0.14 0 0.2 0.2 0 
  Arachidonic (20:4n6) 0 0 0 0 0 0 0 0 0 
  Arachidonic (20:4 T3) 0 0 0 0 0 0 0 0 0 
  (20:5 T3; EPA) 0 0 0.19 0 0 0 0 0 0 
Docosanoic (22:0) 0.08 0.08 0 0.07 0.07 0 0 0 0.29 
  Erucic (22:1n9) 0.09 0.09 0 0.08 0.08 0 0.1 0.1 0 
  (22:5 T3; DPA) 0.27 0.27 1.09 0.24 0.24 1.17 0.2 0.2 1.39 
  (22:6 T3; DHA) 28.16 28.01 26.98 27.09 26.83 26 23.94 24.18 21.46 
Lignoceric (24:0) 0 0 0 0 0 0.2 0 0 0.26 













 APPENDIX C.  Calculation of the Flow Rates  
 
Repetition One 
In the study done by Swaaf et al. (1999), 19 g glucose was used within 
first 40 hours. This value of feed rate was used as the basis of feed rate 
calculations for the batch mode cultivation. Accordingly, our feed rate of media 
for the first 40 h cultivation period (batch- mode) was calculated as: 
(19 g glucose/40 h) x (1 L media/25 g glucose) x (1000 mL/L x h/60 min) = 0.32 
mL/min (for 1 L start up volume) 
For 8.8 L initial volume, the feed rate of media was: 8.8 x 0.32 mL/min = 2.8 
mL/min 
The total volume in both bioreactors after 40 h was calculated as: 
8.8 L + {(2.8 mL/min x 60 min/1 h) x (40 h x 1 L/1000 mL)} = ~ 15.5 L 
According to Swaaf’s study (1999), after 40-43 h the growth rate had started 
decreasing slowly and had ceased completely after 74 h.  This information was 
used to calculate flow rate of culture from the growth vessel to the lipid 
accumulation vessel for the duration of the continuous mode study: 
(15.5 L/34 h) x (h/60 min) x (1000 mL/L) = 7.58 mL/min  
The same flow rate, 7.58 mL/min, was used for the feed rate of fresh 
media to the growth vessel. Since 25 % glucose solution contains 10 times of 
glucose in media, 0.758 mL/min was decided as the feed rate of 25 % glucose 







Repetition Two and Three 
In the study done by Swaaf et al. (1999), 19 g glucose was used within 
the first 40 h of cultivation. This value of feed rate was used as the basis of the 
feed rate calculations for batch mode cultivation. Accordingly, the feed rate of 
media for the first 40 h cultivation period (batch- mode) was calculated as: 
(19 g glucose/40 h) x (1 L media/25 g glucose) x (1000 mL/L x h/60 min) = 0.32 
mL/min (for 1 L start up volume) 
For 5.5 L initial volume, the feed rate of media was: 5.5 x 0.32 mL/min = 1.76 
mL/min 
The total volume in both bioreactors after 40 h was calculated as: 
5.5 L + (1.76 mL/min x 60 min/1 h x 40 h x 1 L/1000 mL) = ~ 9.72 L 
Flow rate of culture from the growth vessel to the lipid accumulation vessel was 
calculated:  
(9.72 L/34 h) x (h/60 min) x (1000 mL/L) = ~4.75 mL/min  
The flow rate of 4.75 mL/min was also used for the feed rate of fresh 
media to the growth vessel. Since 25 % glucose solution contains 10 times of 
glucose in media, 0.475 mL/min was decided as the feed rate of 25 % glucose 
solution to the lipid accumulation vessel. 
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APPENDIX D.   Statistical Analysis  
Since the response variables (OD Growth, OD Cooling,….,DHA Productivity) are 
linearly related to Time, Analysis of Covariance (ANCOVA) is used to compare 





1) OD Growth. 
a) There is a significant difference between Rep 1 and Rep 3 
b) There is a significant difference between Rep 2 and Rep 3 
c) There is no significant difference between Rep 1 and Rep 2. 
 
2) OD Cooling. 
a) There is a significant difference between Rep 1 and Rep 3 
b) There is a significant difference between Rep 2 and Rep 3 
c) There is no significant difference between Rep 1 and Rep 2. 
 
3) Biomass Concentration 
a) There is a significant difference between Rep 1 and Rep 3 
b) There is a significant difference between Rep 2 and Rep 3 
c) There is no significant difference between Rep 1 and Rep 2. 
 
4) %Fat 
a) There is a significant difference between Rep 1 and Rep 2 
b) There is a significant difference between Rep 2 and Rep 3 
c) There is no significant difference between Rep 1 and Rep 3. 
 
5) %DHA 
a) There is a significant difference between Rep 1 and Rep 2 
b) There is a significant difference between Rep 2 and Rep 3 
c) There is no significant difference between Rep 1 and Rep 3. 
 
6) Fat Concentration 
a) There is a significant difference between Rep 1 and Rep 3 
b) There is a significant difference between Rep 2 and Rep 3 
c) There is no significant difference between Rep 1 and Rep 2. 
 
 
7) DHA Concentration 
a) There is a significant difference between Rep 1 and Rep 2 
b) There is a significant difference between Rep 2 and Rep 3 




8) DHA Productivity 
a) There is a significant difference between Rep 1 and Rep 2 
b) There is a significant difference between Rep 2 and Rep 3 
c) There is no significant difference between Rep 1 and Rep 3. 
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Root Mean Square Error 0.062627
Mean of Response 2.1993
Observations (or Sum Wgts) 30
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 3 0.21781693 0.072606 18.5120 
Error 26 0.10197420 0.003922 Prob > F 
C. Total 29 0.31979114 <.0001 
 
Parameter Estimates 
Term   Estimate Std Error t Ratio Prob>|t|
Intercept  2.0094027 0.03228 62.25 <.0001
Time  0.0019794 0.000321 6.17 <.0001
Replication[Rep 1]  -0.036594 0.016752 -2.18 0.0381





Source Nparm DF Sum of Squares F Ratio Prob > F  
Time 1 1 0.14926973 38.0588 <.0001  





Least Squares Means Table 
Level Least Sq Mean  Std Error Mean
Rep 1 2.1596684  0.02097627 2.14700
Rep 2 2.1783165  0.01980592 2.17990
Rep 3 2.2508018  0.01893796 2.25973
 
LS Means Plot 
 
 
LSMeans Differences Tukey HSD 
α= 
0.050   Q= 
2.48489 
 
Level   Least Sq Mean
Rep 3 A   2.2508018
Rep 2   B 2.1783165
Rep 1   B 2.1596684
 















Root Mean Square Error 0.051594
Mean of Response 2.144909
Observations (or Sum Wgts) 30
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 3 0.18948193 0.063161 23.7275 
Error 26 0.06920979 0.002662 Prob > F 
C. Total 29 0.25869172 <.0001 
 
Parameter Estimates 
Term   Estimate Std Error t Ratio Prob>|t|
Intercept  1.9593377 0.026593 73.68 <.0001
Time  0.0019416 0.000264 7.35 <.0001
Replication[Rep 1]  -0.02475 0.013801 -1.79 0.0846





Source Nparm DF Sum of Squares F Ratio Prob > F  
Time 1 1 0.14361025 53.9500 <.0001  





Least Squares Means Table 
Level Least Sq Mean  Std Error Mean
Rep 1 2.1178704  0.01728092 2.10544
Rep 2 2.1234735  0.01631675 2.12503
Rep 3 2.1865181  0.01560170 2.19527
 
LS Means Plot 
 
 
LSMeans Differences Tukey HSD 
α= 
0.050   Q= 
2.48489 
 
Level   Least Sq Mean
Rep 3 A   2.1865181
Rep 2   B 2.1234735
Rep 1   B 2.1178704
 















Root Mean Square Error 0.66595
Mean of Response 2.711622
Observations (or Sum Wgts) 16
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 3 10.140291 3.38010 7.6216 
Error 12 5.321871 0.44349 Prob > F 
C. Total 15 15.462162 0.0041 
 
Parameter Estimates 
Term   Estimate Std Error t Ratio Prob>|t|
Intercept  2.4261001 0.482952 5.02 0.0003
Time  0.0022358 0.004531 0.49 0.6306
Replication[Rep 1]  -0.886385 0.245858 -3.61 0.0036





Source Nparm DF Sum of Squares F Ratio Prob > F  
Time 1 1 0.1079727 0.2435 0.6306  





Least Squares Means Table 
Level Least Sq Mean  Std Error Mean
Rep 1 1.7632941  0.30274484 1.73646
Rep 2 2.5449706  0.30274484 2.57180
Rep 3 3.6407711  0.27187290 3.64077
 
LS Means Plot 
 
 
LSMeans Differences Tukey HSD 
α= 
0.050   Q= 
2.66776 
 
Level   Least Sq Mean
Rep 3 A   3.6407711
Rep 2   B 2.5449706
Rep 1   B 1.7632941
 















Root Mean Square Error 0.025469
Mean of Response 0.108772
Observations (or Sum Wgts) 16
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 3 0.02177279 0.007258 11.1888 
Error 12 0.00778375 0.000649 Prob > F 
C. Total 15 0.02955654 0.0009 
 
Parameter Estimates 
Term   Estimate Std Error t Ratio Prob>|t|
Intercept  0.0362122 0.01847 1.96 0.0736
Time  0.0007202 0.000173 4.16 0.0013
Replication[Rep 1]  0.0358782 0.009403 3.82 0.0025





Source Nparm DF Sum of Squares F Ratio Prob > F  
Time 1 1 0.01120435 17.2734 0.0013  





Least Squares Means Table 
Level Least Sq Mean  Std Error Mean
Rep 1 0.14411267  0.01157815 0.135470
Rep 2 0.06375733  0.01157815 0.072400
Rep 3 0.11683333  0.01039748 0.116833
 
LS Means Plot 
 
 
LSMeans Differences Tukey HSD 
α= 
0.050   Q= 
2.66776 
 
Level   Least Sq Mean
Rep 1 A   0.14411267
Rep 3 A   0.11683333
Rep 2   B 0.06375733
 















Root Mean Square Error 2.585441
Mean of Response 22.38938
Observations (or Sum Wgts) 16
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 3 548.41374 182.805 27.3475 
Error 12 80.21409 6.685 Prob > F 
C. Total 15 628.62782 <.0001 
 
Parameter Estimates 
Term   Estimate Std Error t Ratio Prob>|t|
Intercept  20.784963 1.874981 11.09 <.0001
Time  0.0143704 0.017592 0.82 0.4299
Replication[Rep 1]  5.7864444 0.954502 6.06 <.0001





Source Nparm DF Sum of Squares F Ratio Prob > F  
Time 1 1 4.46056 0.6673 0.4299  





Least Squares Means Table 
Level Least Sq Mean  Std Error Mean
Rep 1 28.008444  1.1753573 27.8360
Rep 2 13.757556  1.1753573 13.9300
Rep 3 24.900000  1.0555020 24.9000
 
LS Means Plot 
 
 
LSMeans Differences Tukey HSD 
α= 
0.050   Q= 
2.66776 
 
Level   Least Sq Mean
Rep 1 A   28.008444
Rep 3 A   24.900000
Rep 2   B 13.757556
 















Root Mean Square Error 0.07883
Mean of Response 0.285974
Observations (or Sum Wgts) 16
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 3 0.28313142 0.094377 15.1876 
Error 12 0.07456928 0.006214 Prob > F 
C. Total 15 0.35770070 0.0002 
 
Parameter Estimates 
Term   Estimate Std Error t Ratio Prob>|t|
Intercept  0.071755 0.057168 1.26 0.2333
Time  0.0020493 0.000536 3.82 0.0024
Replication[Rep 1]  -0.025045 0.029103 -0.86 0.4063





Source Nparm DF Sum of Squares F Ratio Prob > F  
Time 1 1 0.09071337 14.5980 0.0024  





Least Squares Means Table 
Level Least Sq Mean  Std Error Mean
Rep 1 0.25164183  0.03583642 0.227050
Rep 2 0.15312439  0.03583642 0.177716
Rep 3 0.42529324  0.03218205 0.425293
 
LS Means Plot 
 
 
LSMeans Differences Tukey HSD 
α= 
0.050   Q= 
2.66776 
 
Level   Least Sq Mean
Rep 3 A   0.42529324
Rep 1   B 0.25164183
Rep 2   B 0.15312439
 















Root Mean Square Error 0.025124
Mean of Response 0.068023
Observations (or Sum Wgts) 16
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 3 0.02451107 0.008170 12.9441 
Error 12 0.00757441 0.000631 Prob > F 
C. Total 15 0.03208549 0.0005 
 
Parameter Estimates 
Term   Estimate Std Error t Ratio Prob>|t|
Intercept  0.0163896 0.01822 0.90 0.3861
Time  0.0004897 0.000171 2.86 0.0142
Replication[Rep 1]  0.0045343 0.009275 0.49 0.6338





Source Nparm DF Sum of Squares F Ratio Prob > F  
Time 1 1 0.00517953 8.2058 0.0142  





Least Squares Means Table 
Level Least Sq Mean  Std Error Mean
Rep 1 0.06989260  0.01142139 0.064016
Rep 2 0.01818446  0.01142139 0.024061
Rep 3 0.10799770  0.01025672 0.107998
 
LS Means Plot 
 
 
LSMeans Differences Tukey HSD 
α= 
0.050   Q= 
2.66776 
 
Level   Least Sq Mean
Rep 3 A   0.10799770
Rep 1 A   0.06989260
Rep 2   B 0.01818446
 















Root Mean Square Error 7.966397
Mean of Response 22.08731
Observations (or Sum Wgts) 16
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 3 2197.8279 732.609 11.5438 
Error 12 761.5617 63.463 Prob > F 
C. Total 15 2959.3896 0.0008 
 
Parameter Estimates 
Term   Estimate Std Error t Ratio Prob>|t|
Intercept  6.763505 5.777291 1.17 0.2644
Time  0.1474433 0.054204 2.72 0.0186
Replication[Rep 1]  7.1483534 2.941061 2.43 0.0317





Source Nparm DF Sum of Squares F Ratio Prob > F  
Time 1 1 469.5740 7.3991 0.0186  





Least Squares Means Table 
Level Least Sq Mean  Std Error Mean
Rep 1 28.656192  3.6215722 26.8869
Rep 2 5.087979  3.6215722 6.8573
Rep 3 30.779344  3.2522679 30.7793
 
LS Means Plot 
 
 
LSMeans Differences Tukey HSD 
α= 
0.050   Q= 
2.66776 
 
Level   Least Sq Mean
Rep 3 A   30.779344
Rep 1 A   28.656192
Rep 2   B 5.087979
 
Levels not connected by same letter are significantly different. 
 
 
